Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3018301	s-tes-vlik	pmol/l (—)	2291	3060	100.00%	Distribution not available
3018301	s-testo-v	pmol/l (pmol/l)	1078	1387	0.00%
3018301	s-hstesvl	pmol/l (—)	71	83	100.00%	Distribution not available
3018301	s-testovi	pmol/l (—)	61	84	100.00%	Distribution not available
3018301	s-testosteroni,vapaa	pmol/l (pmol/l)	9	10	0.00%	Distribution not available
3018301	testosteroni,vapaa	pmol/l (pmol/l)	9	11	0.00%	Distribution not available
3018301	s-testosteroni,vapaa	nmol/l (pmol/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Testicular dysfunction

182

282

7.25

114.71

1.7

1.4

174.97

212.91

pmol/l

0.56

182

282

Disorders of other endocrine glands

390

1146

3.39

105.62

1.6

1.3

144.53

181.87

pmol/l

2.98

390

1146

Testicular hypofunction

161

253

7.15

100.18

1.7

1.3

175.01

213.98

pmol/l

0.51

161

253

Sleep apnoea

748

2284

2.13

74.01

1.4

1.3

198.78

184.46

pmol/l

0.16

748

2284

Sleep apnoea, including avohilmo

755

2292

2.05

66.93

1.4

1.3

202.77

184.85

pmol/l

0.21

755

2292

Hypopituitarism

156

343

4.74

66.15

1.7

1.3

126.75

207.20

pmol/l

2.21

156

343

Hypogonadotropic hypogonadism

124

227

6.02

65.98

1.7

1.4

141.24

214.39

pmol/l

1.06

124

227

Sleep disorders (combined)

755

2170

1.83

46.80

1.4

1.3

171.92

184.63

pmol/l

0.49

755

2170

Exclusions for E4_PCOS_BROAD

176

541

3.30

46.15

1.6

1.3

129.80

188.99

pmol/l

2.42

176

541

Any death

1708

0.17

36.32

1.2

1.3

88.42

174.92

pmol/l

4.86

1708

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

203

778

2.63

35.78

1.6

1.3

135.82

178.78

pmol/l

2.18

203

778

Other antidepressants

703

2244

1.61

27.69

1.4

1.3

185.34

191.66

pmol/l

0.14

703

2244

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

365

1976

1.80

24.65

1.5

1.3

158.35

181.37

pmol/l

2.40

365

1976

Other diseases of upper respiratory tract

656

2200

1.56

22.78

1.4

1.3

165.54

181.53

pmol/l

1.81

656

2200

Episodal and paroxysmal disorders

669

2216

1.54

21.99

1.4

1.3

170.51

185.85

pmol/l

0.54

669

2216

Exposure to other specified factors

503

2914

1.59

21.17

1.4

1.3

174.44

186.80

pmol/l

0.59

503

2914

Selective serotonin reuptake inhibitors

649

2249

1.51

19.70

1.4

1.3

181.95

191.75

pmol/l

0.22

649

2249

Coxibs

194

483

2.13

18.61

1.6

1.3

217.72

194.70

pmol/l

0.20

194

483

Dislocation, sprain and strain of joints and ligaments of knee

435

2576

1.56

17.10

1.4

1.3

182.15

187.78

pmol/l

0.18

435

2576

Heart failure, not strict

139

1970

0.48

17.00

1.5

1.3

136.85

174.08

pmol/l

2.58

139

1970

Depression or dysthymia

441

1546

1.58

16.62

1.4

1.3

183.33

201.00

pmol/l

0.29

441

1546

Deviated nasal septum

267

1550

1.73

15.95

1.4

1.3

159.95

183.24

pmol/l

1.68

267

1550

Chronic rhinitis, nasopharyngitis and pharyngitis

174

890

1.96

15.65

1.4

1.3

166.76

186.84

pmol/l

0.84

174

890

Insulin medication

145

2407

0.50

15.29

1.3

130.28

192.36

pmol/l

4.94

145

2407

Chronic sinusitis

226

1269

1.79

15.15

1.4

1.3

155.70

182.35

pmol/l

1.81

226

1269

Schizophrenia

913

0.15

14.96

1.3

168.31

194.79

pmol/l

0.33

913

Schizophrenia, schizotypal and delusional disorders

1653

0.37

14.77

1.2

1.3

147.33

205.44

pmol/l

1.85

1653

Schizophrenia or delusion

1651

0.37

14.74

1.2

1.3

147.33

205.56

pmol/l

1.86

1651

Heart failure, strict

1304

0.40

14.62

1.4

1.3

140.62

172.70

pmol/l

1.18

1304

Heart failure,strict

1304

0.40

14.61

1.4

1.3

140.62

174.89

pmol/l

1.30

1304

All-cause Heart Failure

1280

0.40

14.50

1.4

136.03

172.55

pmol/l

1.53

1280

Type 2 diabetes, wide definition

189

2166

0.56

14.17

1.5

1.3

112.47

188.83

pmol/l

6.83

189

2166

Diabetes, insulin treatment (Kela reimbursement)

293

2839

0.62

14.14

1.4

1.3

159.00

189.51

pmol/l

0.45

293

2839

Behavioural syndromes associated with physiological disturbances and physical factors

538

2650

1.44

14.00

1.5

1.3

183.71

186.97

pmol/l

0.06

538

2650

Impotence

279

2.71

13.95

1.9

1.3

160.86

199.15

pmol/l

0.54

279

Sleep disorders

517

2589

1.45

13.68

1.5

1.3

181.93

187.29

pmol/l

0.10

517

2589

Insulin, combination of fast acting with intermediate-acting or long-acting

145

2508

0.53

13.52

1.3

1.4

130.28

189.65

pmol/l

4.49

145

2508

Special screening examination for infectious and parasitic diseases

267

1182

1.67

13.50

1.4

1.3

182.93

210.62

pmol/l

0.63

267

1182

Mouth breathing

288

1794

1.61

13.21

1.5

1.3

159.97

177.81

pmol/l

1.43

288

1794

Abnormalities of breathing

546

2220

1.43

13.20

1.4

1.3

153.14

180.63

pmol/l

6.31

546

2220

Schizophrenia or delusion, excluding more controls

1546

0.39

13.07

1.2

1.3

147.33

202.87

pmol/l

1.71

1546

Chronic diseases of tonsils and adenoids

474

2054

1.46

13.00

1.4

1.3

171.03

182.88

pmol/l

0.90

474

2054

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

284

2707

0.63

12.95

1.4

1.3

161.15

192.03

pmol/l

0.44

284

2707

Irritable bowel syndrome

123

599

2.06

12.79

1.6

1.3

146.21

183.87

pmol/l

1.34

123

599

Peripheral artery disease

984

0.32

12.68

1.2

1.4

114.44

170.86

pmol/l

2.92

984

Major coronary heart disease event excluding revascularizations

127

1638

0.51

12.53

1.3

142.82

176.52

pmol/l

2.81

127

1638

Testicular dysfunction, other/unspecified

6.73

12.47

2.5

1.3

171.40

189.17

pmol/l

0.26

Mental and behavioural disorders due to alcohol, excluding acute intoxication

143

2626

0.54

12.39

1.4

1.3

172.96

187.62

pmol/l

0.46

143

2626

Atherosclerosis, excluding cerebral and coronary sclerosis

859

0.30

11.84

1.2

1.4

110.41

172.12

pmol/l

2.96

859

Mental and behavioural disorders due to alcohol

173

2871

0.58

11.81

1.4

1.3

171.52

188.31

pmol/l

0.63

173

2871

Injuries to the wrist and hand

563

2818

1.39

11.78

1.3

164.95

188.51

pmol/l

1.40

563

2818

Insomnia

493

2546

1.41

11.64

1.5

1.3

181.83

187.63

pmol/l

0.10

493

2546

Stroke, including SAH

106

1533

0.50

11.57

1.4

1.3

146.73

174.37

pmol/l

1.37

106

1533

Depression medications

300

954

1.59

11.52

1.4

1.3

209.90

203.59

pmol/l

0.08

300

954

Oxicams

127

355

2.04

11.45

1.4

1.3

143.51

182.77

pmol/l

3.21

127

355

Myocardial infarction, strict

1363

0.48

11.42

1.3

138.11

176.74

pmol/l

2.74

1363

Exposure to unspecified factor

559

2924

1.38

11.37

1.4

1.3

170.12

187.22

pmol/l

0.90

559

2924

Myocardial infarction

101

1430

0.49

11.36

1.3

135.43

176.89

pmol/l

3.19

101

1430

Alcohol dependence

1495

0.42

11.35

1.3

141.87

179.93

pmol/l

1.70

1495

Recurrent or chronic depression

265

1168

1.60

11.31

1.4

1.3

188.78

211.50

pmol/l

0.23

265

1168

Alcohol use disorder, ICD-based

132

2414

0.54

11.16

1.5

1.3

174.06

189.44

pmol/l

0.44

132

2414

200

2966

0.61

11.16

1.4

1.3

173.30

186.96

pmol/l

0.53

200

2966

COPD

1112

0.40

11.11

1.2

1.4

150.01

172.84

pmol/l

0.51

1112

Stroke, excluding SAH

1412

0.49

11.08

1.5

1.3

146.53

174.93

pmol/l

1.25

1412

Renal failure

1257

0.41

10.96

1.3

1.4

134.24

175.21

pmol/l

1.94

1257

Heart failure and coronary heart disease

960

0.40

10.95

1.4

149.45

178.38

pmol/l

0.83

960

Alcohol use disorder, Swedish definition

192

2891

0.61

10.78

1.4

1.3

170.82

186.39

pmol/l

0.60

192

2891

Diseases of male genital organs

627

2343

1.36

10.77

1.4

1.3

184.42

200.33

pmol/l

0.67

627

2343

COPD, early/later onset

1117

0.40

10.75

1.2

1.4

149.41

171.48

pmol/l

0.48

1117

All chronic kidney diseases

1583

0.50

10.75

1.4

1.3

139.90

177.81

pmol/l

2.70

1583

Transport accidents

297

1677

1.53

10.74

1.4

1.3

173.03

197.52

pmol/l

0.78

297

1677

Cerebrovascular diseases

149

1832

0.57

10.52

1.4

1.3

147.69

172.63

pmol/l

1.60

149

1832

Insulin, intermediate and long-acting

141

2415

0.57

10.47

1.3

131.61

190.30

pmol/l

4.17

141

2415

Oter anti-inflammatory and antirheumatic agents, non-steroids

102

263

2.15

10.45

1.3

160.39

177.50

pmol/l

0.55

102

263

Acetic acid derivatives and related substances

162

462

1.83

10.45

1.4

1.3

228.91

189.53

pmol/l

0.31

162

462

Polycystic ovarian syndrome, consortium definition

107

2.94

10.42

1.1

48.05

11.64

pmol/l

0.51

107

COPD, hospital admissions

1101

0.41

10.34

1.2

1.4

149.41

171.35

pmol/l

0.47

1101

Diabetes mellitus

327

2794

0.68

10.20

1.4

1.3

159.99

189.35

pmol/l

0.48

327

2794

Other joint disorders

562

2179

1.36

10.16

1.4

1.3

178.97

195.03

pmol/l

0.36

562

2179

Medical observation and evaluation for suspected diseases and conditions

458

1666

1.41

10.04

1.5

1.3

156.10

199.37

pmol/l

2.01

458

1666

Malignant neoplasm of bronchus and lung, including Hilmo

380

0.18

10.01

1.1

1.4

155.01

189.59

pmol/l

—

380

COPD related to multimorbidity

894

0.36

9.88

1.3

1.4

155.40

170.73

pmol/l

0.22

894

Diabetes, varying definitions

328

2791

0.69

9.87

1.4

1.3

159.72

189.46

pmol/l

0.49

328

2791

Other chronic obstructive pulmonary disease

1050

0.41

9.82

1.2

1.4

149.41

173.76

pmol/l

0.54

1050

219

3003

0.64

9.76

1.4

1.3

170.03

187.19

pmol/l

0.75

219

3003

Vasomotor and allergic rhinitis

204

1242

1.62

9.68

1.3

299.80

190.34

pmol/l

0.41

204

1242

Ischaemic Stroke, excluding all haemorrhages

1263

0.50

9.45

1.4

150.55

173.67

pmol/l

0.80

1263

Kela-code for severe mental illness

1784

0.52

9.31

1.3

151.63

201.25

pmol/l

1.81

1784

Symptoms and signs involving the circulatory and respiratory systems

598

2255

1.33

9.22

1.4

1.3

221.15

181.38

pmol/l

0.41

598

2255

Heart failure and antihypertensive medication

748

0.40

9.19

1.5

1.3

135.60

185.77

pmol/l

1.78

748

Malignant neoplasm

252

2236

0.66

9.08

1.3

155.80

177.86

pmol/l

2.09

252

2236

Use of pramipexole

413

2.07

9.05

1.5

1.4

142.06

185.42

pmol/l

0.99

413

Acute sinusitis

292

1840

1.47

9.04

1.4

1.3

247.47

180.95

pmol/l

0.34

292

1840

Restless leg syndrome

266

2.35

8.98

1.4

169.28

196.20

pmol/l

0.32

266

Irregular menses

105

3.01

8.98

1.1

58.22

11.77

pmol/l

0.48

105

Solid cancers, helper endpoint

242

2153

0.66

8.94

1.3

152.85

176.93

pmol/l

2.34

242

2153

Diabetes medication

334

2810

0.70

8.91

1.4

1.3

158.10

188.83

pmol/l

0.53

334

2810

Other and unspecified nonorganic psychotic disorders

1072

0.40

8.86

1.1

1.4

133.92

195.30

pmol/l

2.68

1072

Renal tubulo-interstitial diseases

186

2186

0.63

8.75

1.5

1.3

143.42

171.07

pmol/l

2.51

186

2186

Injuries to the shoulder and upper arm

488

2934

1.34

8.70

1.4

1.3

169.10

189.76

pmol/l

1.24

488

2934

COPD, hospital admission 2, with asthma infections

749

0.34

8.64

1.2

1.3

109.43

171.76

pmol/l

2.24

749

Nonorganic sleeping disorders, excluding more controls

119

661

1.81

8.57

1.4

1.3

160.28

179.10

pmol/l

0.86

119

661

Heart failure and bmi 25plus

823

0.44

8.51

1.4

130.22

167.92

pmol/l

0.99

823

Codeine or tramadol medication

620

2609

1.30

8.39

1.4

1.3

179.69

185.34

pmol/l

0.12

620

2609

Malignant neoplasm, wide definition for exclusion

277

2353

0.69

8.35

1.3

158.14

189.19

pmol/l

1.61

277

2353

Ischaemic heart disease, wide definition

215

2021

0.66

8.31

1.3

160.81

174.59

pmol/l

0.91

215

2021

Infections with a predominantly sexual mode of transmission

164

1003

1.64

8.30

1.4

1.3

162.50

183.63

pmol/l

0.98

164

1003

Other chronic obstructive pulmonary disease, including avohilmo

1369

0.53

8.25

1.2

1.4

146.73

172.63

pmol/l

0.95

1369

Use of hypnotics and sedatives

584

2568

1.31

8.23

1.4

1.3

162.39

186.94

pmol/l

1.38

584

2568

Nonorganic sleeping disorders

119

670

1.79

8.21

1.4

1.3

160.28

184.99

pmol/l

0.74

119

670

Type 2 diabetes

313

2584

0.71

8.19

1.4

1.3

158.03

189.08

pmol/l

0.49

313

2584

Infections with a predominantly sexual mode of transmission

225

1388

1.51

8.05

1.4

1.3

179.12

203.77

pmol/l

0.60

225

1388

Cerebrovascular diseases (FINNGEN)

1108

0.52

8.01

1.4

1.3

160.80

179.39

pmol/l

0.68

1108

Tinnitus

116

654

1.78

7.98

1.4

155.03

181.64

pmol/l

0.91

116

654

Mental and behavioural disorders due to psychoactive substance use

226

3097

0.67

7.96

1.4

1.3

160.48

188.86

pmol/l

1.54

226

3097

Codeine

545

2256

1.32

7.94

1.4

1.3

179.63

189.86

pmol/l

0.20

545

2256

Coronary atherosclerosis

171

1701

0.63

7.87

1.3

161.48

176.50

pmol/l

0.91

171

1701

Malignant neoplasm of bronchus and lung

306

0.19

7.86

1.1

1.4

170.59

193.79

pmol/l

—

306

Unspecified mental disorder

112

1923

0.58

7.71

1.3

149.58

198.66

pmol/l

2.08

112

1923

COPD, hospital admissions 3, with asthma pneumonia sepsis

547

0.28

7.68

1.2

1.3

116.58

177.51

pmol/l

1.26

547

Presence of cardiac and vascular implants and grafts

1175

0.54

7.65

1.3

131.19

169.09

pmol/l

3.21

1175

Hernia

518

2655

1.31

7.64

1.3

225.10

180.51

pmol/l

0.43

518

2655

Substance abuse

223

3079

0.68

7.63

1.4

1.3

158.22

188.88

pmol/l

1.72

223

3079

Acute alcohol intoxication

1318

0.50

7.60

1.3

161.16

180.93

pmol/l

0.63

1318

COPD (mode)

780

0.42

7.57

1.2

1.3

148.25

185.09

pmol/l

0.75

780

Biguanides

280

2420

0.70

7.56

1.5

1.3

151.11

185.42

pmol/l

0.49

280

2420

Neurological diseases

502

1910

1.32

7.54

1.4

1.3

185.84

188.10

pmol/l

0.04

502

1910

Type 1 diabetes

1363

0.51

7.50

1.3

158.06

185.55

pmol/l

1.23

1363

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

277

2703

0.71

7.48

1.4

1.3

244.47

176.78

pmol/l

0.33

277

2703

Other diseases of urinary system

256

2070

0.69

7.45

1.4

1.3

141.85

173.45

pmol/l

3.58

256

2070

Any event in cancer register

281

2339

0.71

7.43

1.4

1.3

156.60

175.25

pmol/l

1.64

281

2339

Acute upper respiratory infections

492

2310

1.31

7.34

1.4

1.3

163.28

178.74

pmol/l

1.62

492

2310

Diarrhoea and gastroenteritis of presumed infectious origin

536

2729

1.30

7.34

1.3

191.12

184.21

pmol/l

0.13

536

2729

Non-ischemic cardiomyopathy

741

0.41

7.31

1.3

1.4

132.18

179.68

pmol/l

1.34

741

Other and unspecified tonsillitis

287

1707

1.42

7.27

1.3

172.00

182.53

pmol/l

0.60

287

1707

Hypertensive heart and/or renal disease

675

0.41

7.25

1.2

1.3

141.73

173.21

pmol/l

0.75

675

Chronic periodontitis, complicated

129

2083

0.61

7.22

1.4

1.3

140.36

175.00

pmol/l

2.36

129

2083

Malignant neoplasm of digestive organs

899

0.47

7.22

1.2

1.4

150.65

180.05

pmol/l

1.10

899

Chronic kidney disease

809

0.39

7.20

1.4

124.78

178.67

pmol/l

1.97

809

Other (not insulin) diabetes medications

296

2446

0.72

7.19

1.4

1.3

153.43

186.47

pmol/l

0.49

296

2446

Other bacterial diseases

310

2872

0.72

7.15

1.4

1.3

172.21

186.33

pmol/l

0.19

310

2872

Insulin, fast-acting

1649

0.57

7.08

1.3

146.92

183.48

pmol/l

2.25

1649

Insulin, fast-acting or short human

1645

0.57

7.02

1.3

1.4

146.92

182.40

pmol/l

2.14

1645

Sub-endpoint used in defining T1D endpoints

1309

0.52

6.94

1.3

158.06

186.87

pmol/l

1.13

1309

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

281

2545

0.72

6.86

1.3

184.27

181.86

pmol/l

0.02

281

2545

317

0.19

6.82

1.2

1.4

102.08

199.10

pmol/l

—

317

Hypertensive Heart Disease

619

0.39

6.76

1.2

1.3

145.06

173.40

pmol/l

0.53

619

Other disorders of penis

102

585

1.76

6.74

1.4

1.3

175.55

195.87

pmol/l

0.49

102

585

Injury of muscle and tendon at shoulder and upper arm level

214

1463

1.47

6.72

1.4

1.3

161.60

175.50

pmol/l

0.78

214

1463

Implicit Sepsis

204

2246

0.68

6.69

1.3

146.33

177.67

pmol/l

3.12

204

2246

Angina pectoris

136

1439

0.63

6.66

1.3

158.18

176.60

pmol/l

0.97

136

1439

Aplastic and other anaemias

1051

0.50

6.63

1.4

116.57

171.28

pmol/l

3.05

1051

Other disorders of patella

558

1.76

6.61

1.4

1.3

142.94

174.28

pmol/l

2.08

558

Continuous positive airway pressure

151

807

1.58

6.57

1.5

1.3

118.12

188.25

pmol/l

12.34

151

807

Other medical care

1154

0.53

6.57

1.2

1.4

145.79

175.68

pmol/l

0.97

1154

Medicines for HER+ breast cancer

3.05

6.56

1.6

1.3

173.03

110.68

pmol/l

0.92

Dialysis, with operation codes

486

0.25

6.54

1.2

1.4

73.07

189.03

pmol/l

3.07

486

Hyperkinetic disorders, excluding more controls

466

1.82

6.50

1.2

1.3

183.10

198.24

pmol/l

0.38

466

Bacterial Sepsis

1345

0.58

6.46

1.3

1.4

137.81

177.06

pmol/l

2.19

1345

L02BG Aromatase inhibitors

3.63

6.44

1.8

1.3

177.56

126.07

pmol/l

0.51

Ovarian dysfunction

5.69

6.44

1.2

1.1

15.06

11.56

pmol/l

0.66

Inflammatory diseases of prostate (prostatitis)

115

691

1.68

6.43

1.6

1.3

181.36

187.16

pmol/l

0.13

115

691

Sulfonylureas

682

0.43

6.41

1.4

1.3

119.94

170.10

pmol/l

1.17

682

Hirsutism in women

14.45

6.41

1.0

16.37

11.31

pmol/l

—

STROKE

163

1676

0.66

6.39

1.4

1.3

153.47

178.26

pmol/l

1.62

163

1676

Any dementia, excluding more controls

355

0.27

6.38

1.3

1.4

134.56

159.77

pmol/l

0.33

355

Disturbance of activity and attention

467

1.82

6.36

1.3

184.20

193.80

pmol/l

0.21

467

Lung cancer and mesothelioma

379

0.23

6.27

1.1

1.3

168.11

197.85

pmol/l

—

379

Any dementia

354

0.27

6.26

1.3

1.4

134.56

174.20

pmol/l

0.45

354

Persons encountering health services for specific procedures and health care

379

2983

0.76

6.25

1.3

160.58

187.88

pmol/l

1.82

379

2983

Polyuria

105

620

1.70

6.24

1.4

1.3

154.94

184.25

pmol/l

0.87

105

620

Care involving dialysis

298

0.20

6.23

1.3

1.4

43.45

202.69

pmol/l

—

298

Type 2 diabetes, definitions combined

301

2395

0.74

6.21

1.4

1.3

155.64

187.77

pmol/l

0.48

301

2395

Other specific joint derangements/joint disorders

421

2086

1.31

6.17

1.4

1.3

153.92

193.93

pmol/l

2.44

421

2086

Temporomandibular joint disorders, including avohilmo

152

972

1.54

6.15

1.3

155.33

172.10

pmol/l

0.67

152

972

Acute upper respiratory infections of multiple and unspecified sites

384

2162

1.32

6.15

1.4

1.3

170.52

180.17

pmol/l

0.67

384

2162

COPD, hospital admissions 1, only main diagnosis

755

0.45

6.14

1.3

1.4

173.86

171.08

pmol/l

0.03

755

All kidney diseases

294

2721

0.74

6.14

1.4

1.3

150.26

184.33

pmol/l

2.29

294

2721

Type 2 diabetes, strict (exclude DM1)

302

2397

0.74

6.13

1.4

1.3

155.69

187.61

pmol/l

0.48

302

2397

Type 1 diabetes, wide definition

1170

0.53

6.10

1.2

1.3

166.81

187.75

pmol/l

0.76

1170

Hypertrichosis

10.11

6.04

1.0

1.1

15.64

89.11

pmol/l

1.17

Polycystic ovarian syndrome

6.03

5.99

1.1

15.01

11.57

pmol/l

0.57

Unstable angina pectoris

932

0.53

5.97

1.4

137.07

177.69

pmol/l

2.04

932

Bacterial pneumonia, not elsewhere classified

1197

0.56

5.95

1.2

1.3

157.35

180.30

pmol/l

0.93

1197

Nephropathy related operations

458

0.26

5.95

1.2

1.4

73.07

188.97

pmol/l

3.01

458

Bacterial pneumoniae

1329

0.59

5.89

1.2

1.3

160.66

181.06

pmol/l

0.88

1329

Other extrapyramidal and movement disorders in other diseases

504

1.75

5.86

1.4

157.72

180.39

pmol/l

0.49

504

Status post-ami

671

0.46

5.85

1.4

130.60

182.18

pmol/l

1.86

671

Exclusions for E4_PCOS_CONSORTIUM

209

904

1.45

5.83

1.6

1.3

123.52

176.37

pmol/l

3.51

209

904

Type 2 diabetes, definitions combined, including avohilmo

310

2410

0.75

5.80

1.4

1.3

154.45

188.93

pmol/l

0.55

310

2410

Organic, including symptomatic, mental disorders

844

0.54

5.79

1.2

1.4

127.06

173.13

pmol/l

2.14

844

Myalgia

567

1.70

5.74

1.3

146.08

164.83

pmol/l

0.81

567

Excessive, frequent and irregular menstruation

2.94

5.73

1.1

9.55

12.75

pmol/l

0.96

Subjective visual disturbances

560

1.70

5.72

1.6

1.3

155.47

179.53

pmol/l

0.66

560

Type 1 diabetes, wide definition, subgroup 1

1145

0.54

5.72

1.2

1.3

166.81

187.15

pmol/l

0.73

1145

Early onset COPD

825

0.46

5.69

1.3

1.4

162.08

177.28

pmol/l

0.22

825

Malignant neoplasm of respiratory system and intrathoracic organs

385

0.28

5.67

1.1

1.4

152.77

190.37

pmol/l

0.51

385

Periodontitis

320

2827

0.76

5.66

1.4

1.3

166.01

186.28

pmol/l

1.04

320

2827

Acne

379

1.86

5.62

1.2

1.4

193.14

188.25

pmol/l

0.10

379

Gastro-oesophageal reflux disease

325

2119

1.33

5.57

1.4

1.3

160.89

176.31

pmol/l

0.96

325

2119

Condition for Implicit Sepsis (Organ dysfunction codes)

269

2563

0.74

5.57

1.3

154.35

187.32

pmol/l

1.99

269

2563

Chronic periodontitis, including avohilmo

320

2825

0.76

5.55

1.4

1.3

166.51

186.19

pmol/l

0.99

320

2825

Hypertrophy of breast in women and men

222

2.12

5.55

1.7

1.3

145.78

185.91

pmol/l

0.31

222

Implicit bacterial Sepsis

1248

0.59

5.54

1.4

126.75

176.88

pmol/l

3.20

1248

Arthropathies

539

2182

1.25

5.50

1.4

1.3

182.87

195.17

pmol/l

0.25

539

2182

Lyme disease

125

798

1.57

5.50

1.3

153.64

177.88

pmol/l

0.92

125

798

Spirochaetal infections, other/unspecified

126

806

1.57

5.50

1.3

154.02

177.98

pmol/l

0.91

126

806

Anogenital herpesviral [herpes simplex] infection

243

2.07

5.50

1.6

1.4

148.61

152.32

pmol/l

0.07

243

Other spirochaetal diseases

128

822

1.56

5.49

1.3

154.00

178.18

pmol/l

0.95

128

822

Other predominantly sexually transmitted diseases, not elsewhere classified

113

706

1.61

5.46

1.5

1.3

173.88

192.75

pmol/l

0.56

113

706

Other spirochaetal diseases

126

808

1.56

5.45

1.3

152.78

178.35

pmol/l

1.00

126

808

Diseases of arteries, arterioles and capillaries

159

1722

0.68

5.43

1.3

1.4

147.71

172.18

pmol/l

1.89

159

1722

Erysipelas

172

2192

0.69

5.42

1.4

1.3

203.16

187.62

pmol/l

0.11

172

2192

Other predominantly sexually transmitted diseases, not elsewhere classified

524

1.71

5.42

1.5

1.3

161.11

190.49

pmol/l

0.77

524

Other anaemias

972

0.53

5.38

1.4

115.76

171.67

pmol/l

2.99

972

Myocardial infarction, without ST-elevation

1074

0.56

5.38

1.4

128.44

172.23

pmol/l

2.47

1074

Hyperkinetic disorders

507

1.71

5.36

1.3

1.4

183.10

190.68

pmol/l

0.17

507

Haemorrhoids and perianal venous thrombosis

124

794

1.56

5.34

1.3

168.18

180.87

pmol/l

0.38

124

794

Other menopausal disorders

6.58

5.31

1.1

1.0

15.93

8.07

pmol/l

0.63

Anogenital herpesviral [herpes simplex] infection

143

2.39

5.30

1.6

1.4

139.31

159.32

pmol/l

0.39

143

Implicit Sepsis

248

2455

0.74

5.29

1.3

149.88

176.90

pmol/l

2.90

248

2455

Acute alcohol intoxication, ICD10

1092

0.55

5.29

1.4

1.3

166.97

182.39

pmol/l

0.41

1092

Dipeptidyl peptidase 4 (DPP-4) inhibitors

126

1536

0.66

5.27

1.4

1.3

114.14

173.34

pmol/l

10.03

126

1536

Other and unspecified anaemias

965

0.53

5.23

1.4

115.76

172.20

pmol/l

3.03

965

Non-small cell lung cancer, including Hilmo

287

0.26

5.21

1.1

1.4

155.01

194.72

pmol/l

—

287

Other diseases of intestines

579

2677

1.23

5.19

1.4

1.3

156.32

191.89

pmol/l

2.70

579

2677

Pain in throat and chest

462

2202

1.26

5.19

1.3

177.97

181.31

pmol/l

0.06

462

2202

Contact with and exposure to communicable diseases

169

1164

1.45

5.10

1.4

1.3

341.32

184.46

pmol/l

0.51

169

1164

Bacterial pneumonia (organism specified)

1368

0.62

5.07

1.3

156.53

176.62

pmol/l

0.90

1368

Explicit Sepsis

1245

0.60

5.06

1.4

143.84

174.44

pmol/l

1.38

1245

Migraine with aura

437

1.74

5.04

1.7

1.3

143.62

170.66

pmol/l

1.19

437

Peripheral artery operations in Hilmo

299

0.27

5.04

1.4

124.50

193.28

pmol/l

—

299

Abnormalities of heart beat

136

885

1.51

5.04

1.5

1.3

350.77

173.31

pmol/l

0.45

136

885

Genitourinary diseases

520

2099

1.25

5.03

1.4

1.3

172.78

202.14

pmol/l

1.43

520

2099

Allergic conjunctivitis

224

1591

1.37

5.00

1.4

1.3

183.26

183.01

pmol/l

0.01

224

1591

Opioids

547

2303

1.24

4.98

1.4

1.3

182.02

190.93

pmol/l

0.18

547

2303

Diseases of arteries, arterioles and capillaries (FINNGEN)

922

0.60

4.96

1.2

1.3

151.37

178.90

pmol/l

1.56

922

Secondary polycythaemia

2.90

4.95

1.8

1.3

168.93

163.70

pmol/l

0.05

Poisoning by drugs, medicaments and biological substances

993

0.54

4.95

1.2

1.3

149.01

185.53

pmol/l

0.97

993

Dentofacial anomalies [including malocclusion]

337

2091

1.30

4.93

1.3

164.72

195.90

pmol/l

1.45

337

2091

Schizoaffective disorder

293

0.27

4.93

1.6

1.4

203.41

209.49

pmol/l

—

293

Hypertension, essential

303

2237

0.77

4.86

1.4

1.3

167.91

192.72

pmol/l

0.35

303

2237

Any reimbursement code in KELA

283

1870

0.76

4.85

1.4

1.3

188.36

202.92

pmol/l

0.17

283

1870

Care involving use of rehabilitation procedures

178

2293

0.71

4.84

1.3

169.67

188.74

pmol/l

0.72

178

2293

Coronary artery bypass grafting

650

0.51

4.83

1.3

160.14

182.25

pmol/l

0.51

650

Dementia

452

0.44

4.82

1.2

1.4

108.78

177.10

pmol/l

1.76

452

Poisoning by medicine

877

0.52

4.77

1.3

142.46

185.14

pmol/l

1.15

877

Impingement syndrome of shoulder

118

772

1.53

4.73

1.4

1.3

145.00

166.03

pmol/l

1.14

118

772

Early onset COPD, excluding more controls

768

0.49

4.73

1.3

162.08

185.66

pmol/l

0.38

768

Implicit bacterial Sepsis

1127

0.60

4.71

1.3

1.4

124.46

174.77

pmol/l

2.93

1127

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1067

0.57

4.70

1.2

1.3

128.58

179.50

pmol/l

2.48

1067

Valvular heart disease excluding rheumatic fever

116

1266

0.66

4.70

1.4

1.3

149.34

177.19

pmol/l

1.48

116

1266

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

213

1514

1.37

4.69

1.3

183.84

183.91

pmol/l

0.00

213

1514

Hypertensive diseases

315

2296

0.77

4.69

1.5

1.3

167.08

193.05

pmol/l

0.39

315

2296

Pneumonia, organism unspecified

317

2858

0.78

4.69

1.4

1.3

155.15

189.58

pmol/l

2.13

317

2858

Hypertension

315

2295

0.77

4.68

1.5

1.3

167.08

193.03

pmol/l

0.39

315

2295

Septicaemia

1232

0.61

4.67

1.5

1.3

145.30

171.82

pmol/l

1.37

1232

Chronic laryngitis and laryngotracheitis

273

1.91

4.66

1.5

1.3

170.07

201.19

pmol/l

0.36

273

Suicide or other Intentional self-harm

1032

0.57

4.57

1.2

1.3

132.70

185.21

pmol/l

2.53

1032

Non-rheumatic valve diseases

116

1257

0.66

4.57

1.4

1.3

149.34

177.39

pmol/l

1.49

116

1257

Injuries to the knee and lower leg

597

2740

1.21

4.56

1.3

181.60

185.83

pmol/l

0.15

597

2740

Chronic apical periodontitis

412

2922

0.80

4.52

1.3

158.02

188.80

pmol/l

2.02

412

2922

Erysipelas

254

2547

0.76

4.48

1.4

1.3

188.00

187.05

pmol/l

0.01

254

2547

Soft tissue disorders

571

2424

1.21

4.46

1.4

1.3

184.71

191.35

pmol/l

0.13

571

2424

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

634

0.47

4.41

1.3

1.4

54.09

180.96

pmol/l

7.41

634

Other disorders of veins

122

814

1.49

4.36

1.3

1.4

139.41

161.97

pmol/l

1.47

122

814

Acne vulgaris

310

1.82

4.31

1.3

206.30

190.21

pmol/l

0.39

310

Later onset COPD

339

0.35

4.30

1.1

1.4

117.31

149.26

pmol/l

0.48

339

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

352

3015

0.79

4.29

1.4

1.3

158.90

188.41

pmol/l

1.83

352

3015

Other disorders of male genital organs

240

1.94

4.28

1.7

1.4

171.93

218.41

pmol/l

0.52

240

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1032

0.59

4.25

1.2

1.3

128.58

175.38

pmol/l

2.65

1032

Degenerative diseases of the nervous system

332

0.38

4.22

1.1

1.4

151.45

178.00

pmol/l

0.29

332

Substance abuse, excluding more controls

223

2515

0.75

4.21

1.4

1.3

158.22

189.84

pmol/l

1.61

223

2515

Allergic rhinitis

155

1085

1.42

4.21

1.3

348.59

188.22

pmol/l

0.47

155

1085

Dementia, including avohilmo

492

0.50

4.20

1.2

1.4

117.82

177.73

pmol/l

1.68

492

Bleeding

269

2473

0.77

4.20

1.4

1.3

156.52

189.27

pmol/l

1.60

269

2473

Convulsions, not elsewhere classified

1117

0.61

4.19

1.3

165.64

181.87

pmol/l

0.58

1117

ILD medications: immunosuppressive drugs

207

2566

0.75

4.19

1.3

151.01

192.94

pmol/l

2.89

207

2566

Shoulder lesions

388

1880

1.25

4.19

1.4

1.3

151.55

188.63

pmol/l

1.83

388

1880

Voice disturbances

471

1.64

4.15

1.3

152.23

178.37

pmol/l

0.60

471

Noninflammatory disorders of female genital tract

2.51

4.15

1.2

1.1

11.69

12.64

pmol/l

0.17

Metabolic disorders

335

2573

0.79

4.13

1.4

1.3

148.57

189.26

pmol/l

2.86

335

2573

Other headache syndromes

141

984

1.43

4.13

1.3

210.86

176.88

pmol/l

0.22

141

984

L04AD Calcineurin inhibitors

440

0.38

4.07

1.2

1.4

136.43

196.76

pmol/l

1.00

440

Umbilical hernia

166

1199

1.39

4.05

1.4

1.3

152.85

175.05

pmol/l

1.14

166

1199

Alzheimer disease

208

0.32

4.03

1.0

1.4

132.62

143.63

pmol/l

—

208

Other septicaemia

1065

0.61

4.02

1.5

1.3

137.17

168.33

pmol/l

1.56

1065

Other disorders of urethra and urinary system

1050

0.66

4.00

1.4

1.3

131.77

162.93

pmol/l

1.40

1050

Atrial fibrillation and flutter with reimbursement

864

0.65

3.98

1.4

1.3

150.65

177.31

pmol/l

1.62

864

Other bacterial diseases

370

2906

0.81

3.96

1.4

1.3

177.37

186.40

pmol/l

0.13

370

2906

Injury of muscle and tendon at hip and thigh level

334

1.75

3.94

1.4

172.25

197.25

pmol/l

0.34

334

L04AA Selective immunosuppressants

733

0.53

3.93

1.4

1.3

136.25

186.53

pmol/l

1.81

733

Acute renal failure

627

0.49

3.93

1.2

1.3

113.79

181.52

pmol/l

2.22

627

Sexual dysfunction

2.82

3.88

1.7

1.5

149.14

180.39

pmol/l

0.39

Autoimmune diseases excluding thyroid diseases, strict definition

414

2770

0.82

3.84

1.3

159.00

182.66

pmol/l

3.11

414

2770

Type 1 diabetes, definitions combined

578

0.48

3.83

1.2

1.4

176.67

193.29

pmol/l

0.33

578

Cardiomyopathy (excluding other)

498

0.44

3.83

1.3

154.40

188.01

pmol/l

0.54

498

Acute and transient psychotic disorders

497

0.44

3.81

1.2

1.4

145.47

195.73

pmol/l

0.77

497

Intestinal infectious diseases

470

2955

1.21

3.79

1.4

1.3

170.05

187.09

pmol/l

0.86

470

2955

Diseases of the musculoskeletal system and connective tissue

344

1374

1.26

3.77

1.5

1.3

199.44

205.00

pmol/l

0.06

344

1374

Dermatophytosis

326

2610

1.25

3.76

1.4

1.3

165.91

189.32

pmol/l

1.20

326

2610

Mycoses

424

3034

1.22

3.74

1.3

166.47

186.90

pmol/l

1.21

424

3034

Unspecific neurodegenerative disorder

378

0.47

3.74

1.1

1.4

107.17

148.84

pmol/l

1.23

378

Condition for Implicit Sepsis (Organ dysfunction codes)

311

2683

0.80

3.74

1.3

159.22

187.07

pmol/l

1.64

311

2683

Bacterial infection, other or unspecified

126

1547

0.71

3.74

1.3

122.90

171.98

pmol/l

5.25

126

1547

Other degenerative diseases of the nervous system

452

0.49

3.73

1.1

1.3

141.16

174.95

pmol/l

0.90

452

Polycystic ovarian syndrome, broad definition

2.91

3.73

1.1

13.39

12.64

pmol/l

0.13

Type 1 diabetes, strict (exclude DM2)

570

0.49

3.69

1.2

1.4

176.67

192.71

pmol/l

0.31

570

Other disorders of fluid, electrolyte and acid-base balance

781

0.57

3.68

1.4

1.3

97.54

177.67

pmol/l

4.04

781

Symptoms and signs involving the skin and subcutaneous tissue

280

2163

1.27

3.67

1.3

161.78

185.37

pmol/l

0.88

280

2163

Caries of dentine, including avohilmo

289

1866

0.79

3.66

1.3

155.45

185.69

pmol/l

3.38

289

1866

Propionic acid derivatives

141

497

1.43

3.66

1.3

177.04

196.61

pmol/l

1.22

141

497

Tonsillectomy and adenotomy

334

1865

1.25

3.66

1.4

1.3

169.20

200.98

pmol/l

1.29

334

1865

Sleep disorders, other/unspecified

2.49

3.64

1.3

1.4

158.83

173.50

pmol/l

0.21

Pacemaker

660

0.54

3.63

1.4

138.31

174.96

pmol/l

1.10

660

Cardiomyopathies, Primary/intrinsic

473

0.44

3.63

1.2

1.3

157.75

189.24

pmol/l

0.47

473

Hypothyroidism (congenital or acquired)

195

821

1.35

3.62

1.4

1.3

301.83

198.68

pmol/l

0.36

195

821

Disorders of gallbladder, biliary tract and pancreas

294

2327

0.80

3.62

1.3

155.83

171.01

pmol/l

1.26

294

2327

Disorders of lens

184

1530

0.75

3.61

1.3

146.20

173.68

pmol/l

2.23

184

1530

Disorders of skin appendages

224

1723

1.30

3.60

1.3

169.84

181.14

pmol/l

0.57

224

1723

Autoimmune diseases excluding thyroid diseases

426

2812

0.83

3.60

1.3

157.65

182.08

pmol/l

3.36

426

2812

Alcohol withdrawal state with delirium

342

0.35

3.60

1.8

1.4

141.88

196.79

pmol/l

0.74

342

Cardiomyopathy

672

0.53

3.59

1.3

191.41

180.19

pmol/l

0.19

672

Diabetic nephropathy, excluding more controls

331

0.40

3.59

1.5

90.63

160.58

pmol/l

1.27

331

Artrosis, including avohilmo

455

2060

1.21

3.58

1.4

1.3

234.55

175.87

pmol/l

0.48

455

2060

Monoamine oxidase A inhibitors

285

1.76

3.55

1.3

1.4

149.80

166.43

pmol/l

0.43

285

Other arthrosis

256

1385

1.28

3.52

1.4

1.3

154.34

176.66

pmol/l

2.64

256

1385

Anti-inflammatory and antirheumatic products, non-steroids

140

497

1.42

3.51

1.3

175.54

196.61

pmol/l

1.35

140

497

Other benign neoplasms of skin

123

867

1.42

3.50

1.4

1.3

148.14

173.86

pmol/l

1.17

123

867

Bacterial infection, other or unspecified

147

1695

0.73

3.50

1.3

131.43

171.96

pmol/l

3.92

147

1695

Used for control exclusion in common control thyroid runs

610

2624

1.18

3.44

1.4

1.3

200.20

184.80

pmol/l

0.14

610

2624

Disorders of lipoprotein metabolism and other lipidaemias

295

2278

0.80

3.44

1.4

1.3

151.08

189.05

pmol/l

2.20

295

2278

Intestinal infectious diseases

565

2736

1.18

3.43

1.4

1.3

178.17

184.47

pmol/l

0.13

565

2736

Alzheimer disease, excluding more controls

164

0.32

3.40

1.0

1.4

148.99

173.79

pmol/l

—

164

Generalized anxiety disorder

505

1.55

3.40

1.5

1.3

150.35

173.65

pmol/l

0.84

505

Gout, idiopatic and unspecified

850

0.60

3.39

1.7

1.4

141.26

173.79

pmol/l

1.16

850

Diseases of the ear and mastoid process

617

2643

1.17

3.39

1.4

1.3

164.84

189.92

pmol/l

1.47

617

2643

Raynaud syndrome

167

1.98

3.38

1.5

1.4

141.87

216.17

pmol/l

0.71

167

Pain in joint

345

1788

1.23

3.35

1.4

1.3

153.93

196.07

pmol/l

2.10

345

1788

Peripheral arterial reconstruction

330

0.36

3.34

1.2

1.4

100.17

186.06

pmol/l

1.61

330

Hypothyroidism, levothyroxine purchases

191

814

1.33

3.33

1.4

1.3

305.53

198.37

pmol/l

0.37

191

814

Hypothyroidism and >3 levothyroxin purchases

191

814

1.33

3.33

1.4

1.3

305.53

198.37

pmol/l

0.37

191

814

Other retinal disorders

153

1602

0.74

3.30

1.4

1.3

156.64

178.73

pmol/l

1.60

153

1602

Senile cataract

150

1243

0.74

3.30

1.3

141.89

173.30

pmol/l

2.25

150

1243

Combinations of oral blood glucose lowering drugs

1149

0.66

3.30

1.8

1.3

139.98

170.85

pmol/l

1.27

1149

Pain and other conditions associated with female genital organs and menstrual cycle

2.73

3.28

1.1

7.84

12.81

pmol/l

2.09

Other disorders of prostate

2.31

3.27

1.5

1.4

199.89

257.66

pmol/l

0.26

Diabetic maculopathy, excluding more controls

466

0.47

3.26

1.4

1.3

101.49

184.86

pmol/l

4.55

466

Dorsopathies

555

2398

1.18

3.23

1.4

1.3

189.21

190.17

pmol/l

0.02

555

2398

Disorders of refraction and accommodation

117

828

1.41

3.22

1.3

186.34

183.94

pmol/l

0.04

117

828

Varicose veins of other sites

325

1.67

3.21

1.5

1.4

176.90

176.28

pmol/l

0.01

325

Disorders of lacrimal system

115

813

1.41

3.20

1.4

1.3

172.08

175.75

pmol/l

0.06

115

813

Extracorporeal dialysis

204

0.29

3.20

1.3

1.5

43.45

214.29

pmol/l

—

204

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

542

0.51

3.19

1.3

1.4

135.24

182.94

pmol/l

1.13

542

Vulvovaginal ulceration/inflammation in other diseases

5.35

3.19

1.0

1.3

5.50

15.17

pmol/l

—

Mandibular retrognathia

157

1.98

3.16

1.3

1.4

201.84

233.96

pmol/l

0.22

157

Amputation

235

0.34

3.16

1.5

1.4

119.34

207.88

pmol/l

—

235

Dilated cardiomyopathy

419

0.45

3.16

1.2

1.4

156.78

189.36

pmol/l

0.44

419

Recurrent dislocation of patella

104

2.22

3.15

1.2

1.3

152.17

169.00

pmol/l

0.32

104

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

460

0.48

3.15

1.3

1.4

155.25

188.82

pmol/l

0.47

460

Symptoms and signs involving speech and voice

636

1.46

3.15

1.3

143.48

175.97

pmol/l

1.13

636

Dental caries, including avohilmo

272

1736

0.80

3.15

1.3

156.81

185.02

pmol/l

2.79

272

1736

Chondromalacia

2.65

3.14

1.5

1.3

156.09

166.15

pmol/l

0.13

Nonischemic cardiomyopathy

346

0.40

3.11

1.0

1.4

179.78

196.20

pmol/l

0.17

346

Sequelae of cerebrovascular disease

823

0.64

3.10

1.4

125.53

174.69

pmol/l

2.30

823

Alzheimer disease, including avohilmo

256

0.41

3.10

1.1

1.4

121.18

147.26

pmol/l

0.40

256

Internal derangement of knee

195

1502

1.29

3.08

1.4

1.3

161.01

180.08

pmol/l

1.44

195

1502

Diseases of pulp and periapical tissues, including avohilmo

409

2532

0.84

3.08

1.3

155.25

194.11

pmol/l

2.79

409

2532

Other viral diseases, not elsewhere classified

135

987

1.36

3.05

1.3

151.35

187.04

pmol/l

1.89

135

987

Gout, FINNGEN

982

0.65

3.05

1.7

1.4

143.32

173.14

pmol/l

1.25

982

Extrapyramidal and movement disorders

119

858

1.39

3.03

1.4

158.77

172.68

pmol/l

0.44

119

858

Other and unspecified disorders of skin and subcutaneous tissue

106

2.18

3.03

1.0

1.3

78.76

164.43

pmol/l

4.02

106

Alcohol abuse, main dg, excluding more controls

798

0.61

3.02

1.4

163.07

176.11

pmol/l

0.33

798

Migraine with aura and triptan purchases

225

1.78

3.01

1.5

1.3

137.18

141.91

pmol/l

0.09

225

Mesial bite

4.36

3.01

1.4

1.1

149.74

176.76

pmol/l

—

Donors of organs and tissues

2.79

3.00

1.6

1.4

153.77

181.88

pmol/l

0.33

Pneumonias (Asthma/COPD co-morbidities)

378

3034

0.84

2.97

1.4

1.3

157.10

188.91

pmol/l

2.15

378

3034

Other congenital malformations of circulatory system

2.66

2.97

1.5

1.4

170.16

175.39

pmol/l

0.08

Mild mental retardation

0.00

2.97

0.0

1.4

—

183.00

—

Benign neoplasms

563

2665

1.17

2.97

1.4

1.3

161.01

189.77

pmol/l

1.90

563

2665

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

669

0.58

2.96

1.3

136.52

187.92

pmol/l

1.51

669

Non-small cell lung cancer

175

0.28

2.96

1.0

1.4

154.02

163.18

pmol/l

—

175

Other dorsopathies, not elsewhere classified

534

2389

1.17

2.95

1.4

1.3

189.24

189.82

pmol/l

0.01

534

2389

Other enthesopathies

118

854

1.38

2.95

1.4

1.3

158.61

166.52

pmol/l

0.31

118

854

Alcohol abuse, main dg

793

0.62

2.95

1.4

1.3

163.07

185.19

pmol/l

0.52

793

Other cataract

959

0.69

2.94

1.4

1.3

146.55

174.82

pmol/l

1.14

959

Follow-up examination after treatment for conditions other than malignant neoplasms

107

988

0.72

2.94

1.2

1.3

143.47

178.02

pmol/l

2.74

107

988

Torsion of testis

128

2.07

2.94

1.2

1.3

202.98

200.53

pmol/l

0.04

128

Inflammatory diseases of female pelvic organs

127

1.91

2.93

1.0

1.1

9.52

27.36

pmol/l

0.63

127

Cystitis

151

1190

0.75

2.93

1.4

1.3

134.06

166.07

pmol/l

1.99

151

1190

Other disorders of lacrimal gland

663

1.44

2.92

1.5

1.3

172.47

177.83

pmol/l

0.08

663

Calcific aortic valvular stenosis, including rheumatic fever

572

0.56

2.92

1.3

1.4

107.84

178.34

pmol/l

2.85

572

Benign neoplasm: Skin of other and unspecified parts of face

184

1.85

2.91

1.3

1.5

133.70

166.14

pmol/l

1.12

184

Calcific aortic valvular stenosis, diagnosis (helper)

570

0.56

2.88

1.3

1.4

107.84

178.45

pmol/l

2.85

570

Operations 2 for CAVS

570

0.56

2.88

1.3

1.4

107.84

178.45

pmol/l

2.85

570

Calcific aortic valvular stenosis

570

0.56

2.88

1.3

1.4

107.84

178.45

pmol/l

2.85

570

Calcific aortic valvular stenosis, operated

570

0.56

2.88

1.3

1.4

107.84

178.45

pmol/l

2.85

570

Neurological diseases, wide definition

199

773

1.30

2.87

1.5

1.3

217.65

202.13

pmol/l

0.13

199

773

Persons with potential health hazards related to communicable diseases

195

1512

1.28

2.87

1.4

1.3

319.77

182.02

pmol/l

0.52

195

1512

Glomerular disorders in diseases classified elsewhere

402

0.47

2.85

1.7

1.4

134.94

195.33

pmol/l

1.18

402

Other CVD (FINNGEN)

313

0.47

2.85

1.2

1.3

159.58

179.82

pmol/l

0.38

313

All pneumoniae

382

3036

0.84

2.85

1.4

1.3

159.12

188.79

pmol/l

1.93

382

3036

Colorectal cancer

560

0.56

2.84

1.2

1.4

174.47

184.09

pmol/l

0.18

560

Ethmoidectomy

447

1.53

2.84

1.4

149.30

187.87

pmol/l

0.91

447

Use of biperiden

173

0.29

2.83

1.6

1.4

90.72

216.59

pmol/l

—

173

Other sexually transmitted chlamydial diseases

432

1.53

2.81

1.3

217.98

184.26

pmol/l

1.41

432

Substance use, excluding alcohol

1108

0.68

2.81

1.2

1.3

139.98

193.03

pmol/l

2.24

1108

Hallux rigidus

223

1.75

2.80

1.5

1.3

151.86

178.40

pmol/l

0.88

223

Ganglion

529

1.48

2.80

1.4

1.3

156.02

166.35

pmol/l

0.28

529

Cervical disc disorders

159

1216

1.31

2.79

1.2

1.3

153.45

169.80

pmol/l

0.99

159

1216

Visual disturbances

177

1374

1.29

2.78

1.5

1.3

161.63

175.51

pmol/l

0.68

177

1374

Cough

138

978

1.34

2.78

1.3

176.47

175.95

pmol/l

0.01

138

978

Anomalies of dental arch relationship, including avohilmo

536

1.45

2.77

1.3

174.50

194.62

pmol/l

0.46

536

Pure hypercholesterolaemia

254

2043

0.81

2.76

1.4

1.3

146.71

189.41

pmol/l

2.31

254

2043

Fever of other and unknown origin

172

1965

0.78

2.75

1.3

157.82

190.38

pmol/l

1.32

172

1965

Oligomenorrhoea

8.35

2.75

1.4

1.0

16.68

9.28

pmol/l

—

Transient global amnesia

131

1.99

2.75

1.2

1.4

164.44

160.81

pmol/l

0.06

131

Type 1 diabetes, strict definition

499

0.54

2.74

1.2

1.4

182.67

193.88

pmol/l

0.20

499

Artificial joint operation, meniscal resection

436

2405

1.18

2.73

1.4

1.3

191.25

184.07

pmol/l

0.11

436

2405

Glomerular diseases

615

0.58

2.72

1.5

1.3

153.65

186.00

pmol/l

0.80

615

Gout, unspecified

677

0.60

2.71

1.7

1.4

151.87

178.29

pmol/l

0.70

677

Hypertrophy of (infrapatellar) fat pad

3.51

2.71

1.9

1.3

258.20

167.82

pmol/l

—

Examination and encounter for administrative purposes

132

1.98

2.70

1.3

1.4

163.87

168.81

pmol/l

0.10

132

Later onset COPD, excluding more controls

262

0.44

2.67

1.1

1.3

117.31

165.46

pmol/l

0.82

262

FESS (DNB20)

430

1.52

2.66

1.4

151.73

189.38

pmol/l

0.83

430

Obesity related asthma

148

1131

1.31

2.64

1.4

1.3

148.07

176.56

pmol/l

1.67

148

1131

Fissure and fistula of anal and rectal regions

113

830

1.36

2.63

1.4

1.3

169.87

184.93

pmol/l

0.46

113

830

Other sleep disorders

312

1.61

2.63

1.2

1.3

164.40

175.63

pmol/l

0.26

312

Acute tubulo-interstitial nephritis

109

1276

0.74

2.62

1.4

1.3

143.69

165.64

pmol/l

0.99

109

1276

Rotator cuff syndrome

279

1642

1.22

2.62

1.4

1.3

144.82

171.74

pmol/l

3.79

279

1642

Meniscus derangement

284

1571

1.22

2.62

1.4

1.3

194.25

195.52

pmol/l

0.01

284

1571

Sequelae of other external causes

120

2.01

2.61

1.4

196.38

164.29

pmol/l

0.58

120

Dental caries

1173

0.71

2.61

1.3

138.10

181.30

pmol/l

3.15

1173

Unspecified/other endometriosis

3.61

2.57

1.0

9.89

13.78

pmol/l

—

Excessive earwax

222

1746

1.24

2.57

1.5

1.3

175.40

177.57

pmol/l

0.06

222

1746

Herpesviral [herpes simplex] infections

556

1.44

2.57

1.7

1.3

167.84

174.60

pmol/l

0.13

556

Alzheimer’s disease, strict definition

162

0.36

2.56

1.0

1.3

166.70

144.99

pmol/l

—

162

Panhypopituitarism

2.76

2.56

1.5

37.51

184.88

pmol/l

10.64

Inguinal hernia, bilateral

410

1.52

2.56

1.3

1.4

190.05

192.44

pmol/l

0.03

410

Gout

831

0.68

2.53

1.7

1.3

143.32

173.14

pmol/l

1.69

831

Lumbar disc prolapse

317

2029

1.20

2.53

1.4

1.3

160.91

189.06

pmol/l

1.29

317

2029

Inguinal or femoral hernia, bilateral

411

1.52

2.53

1.3

1.4

190.05

192.55

pmol/l

0.04

411

Dystonia

2.28

2.51

1.5

1.3

173.51

163.04

pmol/l

0.19

Insulin, fast-acting (human)

711

0.63

2.50

1.3

1.4

166.50

197.84

pmol/l

0.86

711

Vasomotor rhinitis (mode)

136

1.92

2.50

1.3

126.52

163.18

pmol/l

0.92

136

Female infertility

2.26

2.50

1.2

1.1

11.06

13.05

pmol/l

0.52

Diabetic nephropathy

337

0.47

2.50

1.5

90.63

157.20

pmol/l

1.20

337

Disorders of choroid and retina

247

2141

0.82

2.49

1.4

1.3

161.78

175.82

pmol/l

1.11

247

2141

Persistent delusional disorders

257

0.39

2.49

1.4

182.40

197.85

pmol/l

—

257

Non-seminoma of testis, including Hilmo

2.64

2.49

1.2

1.5

131.10

213.13

pmol/l

0.91

Anaemias

725

0.70

2.48

1.3

141.03

196.62

pmol/l

2.74

725

Other disorders of adrenal gland

2.33

2.48

1.1

1.4

85.03

181.04

pmol/l

2.43

Persons encountering health services for other counselling and medical advice, not elsewhere classified

452

2851

0.86

2.48

1.4

1.3

158.25

187.06

pmol/l

2.09

452

2851

Other intervertebral disc disorders

412

2116

1.17

2.47

1.4

1.3

164.91

188.62

pmol/l

1.08

412

2116

Thoracic aortic aneurysm

520

1.45

2.46

1.2

1.4

141.82

184.04

pmol/l

1.35

520

Amenorrhoea

3.82

2.46

1.0

11.86

14.72

pmol/l

—

Colorectal adenocarcinoma

469

0.55

2.45

1.2

1.4

178.00

185.52

pmol/l

0.12

469

Paracetamol or NSAID medication

101

365

1.40

2.45

1.3

1.2

176.77

203.89

pmol/l

1.68

101

365

Adverse effects, not elsewhere classified

463

1.47

2.44

1.3

1.4

122.64

182.33

pmol/l

1.99

463

Myocardial infarction, unclassifiable

397

0.54

2.44

1.3

1.4

101.46

183.25

pmol/l

2.44

397

Malignant neoplasm of colon, including Hilmo

417

0.53

2.43

1.2

1.4

153.02

190.21

pmol/l

0.69

417

Allergic asthma (mode), excluding more controls

116

849

1.34

2.43

1.3

177.29

199.17

pmol/l

0.78

116

849

Viral infections characterized by skin and mucous membrane lesions

394

2880

1.17

2.42

1.4

1.3

168.45

185.52

pmol/l

0.89

394

2880

Allergic asthma (mode)

116

850

1.34

2.41

1.3

177.29

199.52

pmol/l

0.80

116

850

Alcoholic liver disease

402

0.52

2.40

1.4

133.46

190.97

pmol/l

1.16

402

Procedures for purposes other than remedying health state

3.35

2.39

1.1

1.2

174.24

160.20

pmol/l

—

Retinal breaks without detachment

384

1.51

2.39

1.2

1.3

176.10

182.56

pmol/l

0.09

384

Fibrosis and cirrhosis of liver

177

0.34

2.39

1.0

1.5

196.98

216.48

pmol/l

—

177

Hard cardiovascular diseases

312

2214

0.84

2.38

1.5

1.3

155.32

189.29

pmol/l

1.80

312

2214

Other diseases of blood and blood-forming organs

190

1.75

2.37

1.7

1.4

161.65

164.31

pmol/l

0.03

190

Pollen allergy

642

1.39

2.35

1.2

1.4

177.35

194.65

pmol/l

0.43

642

Diarrhoea and gastroenteritis of presumed infectious origin

348

2662

1.18

2.35

1.3

172.17

188.58

pmol/l

0.66

348

2662

Hyperlipidaemia, other/unspecified

1208

0.74

2.35

1.4

1.3

150.15

178.75

pmol/l

1.67

1208

Type 1 diabetes, strict definition, subgroup 1

474

0.57

2.34

1.2

1.4

182.67

192.09

pmol/l

0.17

474

Fracture of femur

455

0.58

2.33

1.3

1.4

204.16

186.01

pmol/l

0.27

455

Diseases of pulp and periapical tissues and dental caries

254

1577

0.82

2.33

1.3

159.62

187.34

pmol/l

2.40

254

1577

Rubella [German measles]

261

1.63

2.32

1.2

1.3

166.61

189.25

pmol/l

0.23

261

Undetermined asthma

307

1.57

2.31

1.3

1.2

156.72

205.60

pmol/l

0.81

307

Valvular operations

524

0.59

2.31

1.3

160.57

184.03

pmol/l

0.35

524

Dislocation, sprain and strain of joints and ligaments at neck level

519

1.43

2.30

1.3

181.60

187.46

pmol/l

0.09

519

Complications of surgical and medical care, not elsewhere classified

334

2692

0.85

2.29

1.4

1.3

154.24

186.13

pmol/l

1.77

334

2692

Other specified/unspecified bacterial intestinal infections

141

1.85

2.27

1.4

1.3

146.15

225.03

pmol/l

0.61

141

Amputation of toe

170

0.35

2.27

1.5

1.4

157.90

218.24

pmol/l

—

170

Cervicobrachial syndrome

571

1.40

2.26

1.2

1.3

153.33

164.56

pmol/l

0.34

571

Undetermined asthma, excluding more controls

309

1.56

2.25

1.3

1.2

156.72

203.19

pmol/l

0.75

309

Caries of dentine

1042

0.72

2.25

1.4

1.3

128.29

182.13

pmol/l

4.29

1042

Polycystic kidney disease

0.00

2.25

0.0

1.2

—

168.62

—

Cardiac arrest

257

0.46

2.25

1.1

1.3

232.46

181.37

pmol/l

1.37

257

Adenocarcinoma and ductal carcinoma of pancreas

0.00

2.24

0.0

1.4

—

168.41

—

Skin changes due to chronic exposure to nonionizing radiation

496

1.41

2.23

1.2

1.4

151.16

174.46

pmol/l

0.55

496

Spirochaetal infections, other/unspecified

179

1.74

2.22

1.3

1.4

141.88

208.59

pmol/l

0.66

179

Early syphilis

2.45

2.21

1.5

199.18

170.84

pmol/l

0.61

Hyperfunction of pituitary gland

2.20

2.21

1.4

123.61

179.52

pmol/l

1.18

Melanocytic naevi

105

787

1.34

2.20

1.6

1.3

187.71

177.13

pmol/l

0.25

105

787

Other enthesopathy of foot (+metatarsalgia)

172

1.75

2.20

1.5

1.3

168.79

163.16

pmol/l

0.09

172

Hypertensive diseases (excluding secondary)

246

1722

0.83

2.19

1.5

1.3

175.41

200.48

pmol/l

0.27

246

1722

Follow-up care involving plastic surgery

2.51

2.18

1.2

76.78

133.80

pmol/l

1.25

Open wound of head

224

2610

0.83

2.18

1.4

1.3

182.09

191.13

pmol/l

0.29

224

2610

Blepharochalasis

401

1.47

2.17

1.2

1.3

135.54

182.46

pmol/l

1.14

401

Disturbances of skin sensation

105

790

1.33

2.16

1.4

1.3

150.86

175.29

pmol/l

0.85

105

790

Bronchitis

488

2689

1.14

2.15

1.4

1.3

166.07

179.44

pmol/l

1.33

488

2689

Other noninflammatory disorders of vulva and perineum

4.29

2.15

1.0

8.55

13.31

pmol/l

—

Missing teeth due to accident, extraction or parodontitis

145

1727

0.79

2.15

1.5

1.3

135.41

173.23

pmol/l

2.95

145

1727

Gout, strict definition

575

0.62

2.15

1.8

1.4

140.46

181.45

pmol/l

1.06

575

Gastrointestinal diseases

333

1415

1.18

2.14

1.4

1.3

166.91

193.06

pmol/l

2.24

333

1415

Oxycodone

1023

0.73

2.13

1.3

101.00

172.11

pmol/l

7.64

1023

Other disorders of eyelid

103

736

1.33

2.13

1.4

1.3

162.36

170.88

pmol/l

0.20

103

736

Impacted maxillary molar

159

1.77

2.13

1.2

1.3

190.79

175.80

pmol/l

0.19

159

Chronic pancreatitis

511

0.60

2.12

1.1

1.4

205.31

188.28

pmol/l

0.22

511

Ulcer of lower limb, not elsewhere classified

372

0.54

2.12

1.6

1.4

125.72

192.44

pmol/l

1.34

372

Other salmonella infections

109

1.94

2.10

1.8

1.3

126.10

163.32

pmol/l

0.82

109

Actinic keratosis

481

1.41

2.10

1.2

1.4

153.50

175.31

pmol/l

0.49

481

Presence of other functional implants

119

1069

0.77

2.09

1.3

242.46

165.32

pmol/l

0.49

119

1069

Chronic viral hepatitis

302

0.49

2.05

1.2

1.4

176.60

204.28

pmol/l

0.22

302

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

456

0.59

2.05

1.2

1.3

134.55

208.61

pmol/l

1.11

456

Secondary hypertension

350

0.53

2.05

1.6

1.3

112.22

182.86

pmol/l

2.34

350

Hernia of abdominal wall

210

1732

1.21

2.04

1.4

1.3

160.21

172.67

pmol/l

0.59

210

1732

Disturbances of smell and taste

2.18

2.04

1.4

1.3

203.67

163.22

pmol/l

0.72

Major coronary heart disease event

304

2154

0.85

2.04

1.4

1.3

156.76

188.19

pmol/l

1.56

304

2154

Pneumonitis due to solids and liquids

194

0.41

2.03

1.3

1.4

94.32

213.21

pmol/l

—

194

Other and unspecified disorders of vitreous body

101

753

1.32

2.02

1.3

1.4

432.50

171.59

pmol/l

0.51

101

753

Candidiasis

559

1.38

2.01

1.2

1.3

159.52

169.54

pmol/l

0.19

559

Car occupant injured in other and unspecified transport accidents

697

1.34

1.99

1.3

1.4

163.54

189.26

pmol/l

0.82

697

Early syphilis

2.31

1.99

1.5

199.18

176.55

pmol/l

0.44

Type1 diabetes, definitions combined, early onset

349

0.54

1.98

1.2

1.4

198.03

192.12

pmol/l

0.08

349

Pectus excavatum

3.42

1.98

1.1

1.2

168.33

229.72

pmol/l

—

Pectus excavatum

3.41

1.98

1.1

1.2

168.33

229.72

pmol/l

—

Asthma and allergy

429

1.43

1.97

1.3

182.78

209.08

pmol/l

0.49

429

Benign neoplasm of male genital organs

2.10

1.97

1.7

1.4

113.16

172.24

pmol/l

1.59

Orthopaedic devices associated with adverse incidents

3.36

1.97

2.4

1.1

82.47

182.46

pmol/l

—

Asthma and allergy, excluding more controls

430

1.43

1.95

1.3

182.78

208.69

pmol/l

0.48

430

Unspecified acute lower respiratory infection

669

0.67

1.95

1.1

1.4

170.24

188.09

pmol/l

0.39

669

Glucosamine medication

569

1.33

1.95

1.3

1.4

154.02

178.87

pmol/l

0.66

569

Blepharospasm

4.59

1.95

1.0

1.1

195.38

182.07

pmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

127

1.82

1.94

1.7

1.4

109.22

164.92

pmol/l

1.54

127

Other neurological diseases

190

1813

0.82

1.94

1.4

1.3

138.87

173.07

pmol/l

3.42

190

1813

Unspecified kidney failure

205

0.44

1.94

1.1

1.5

152.31

214.71

pmol/l

—

205

Iron deficiency

2.98

1.94

1.3

1.2

236.97

132.94

pmol/l

—

Other protozoal intestinal diseases

2.46

1.93

1.6

1.4

207.09

178.65

pmol/l

0.44

Malignant neoplasm of prostate, including Hilmo

136

1019

0.79

1.93

1.3

1.4

127.85

178.79

pmol/l

3.95

136

1019

Metatarsalgia

157

1.72

1.92

1.4

1.3

166.65

163.07

pmol/l

0.05

157

Foreign body on external eye

1050

0.74

1.92

1.4

1.3

163.24

188.29

pmol/l

1.07

1050

Any operation in hilmo

165

1.53

1.92

1.4

1.3

191.24

204.18

pmol/l

0.35

165

Other pulmonary diagnosis

424

1854

1.15

1.91

1.4

1.3

162.42

185.06

pmol/l

2.38

424

1854

Adrenocortical insufficiency

2.25

1.91

1.1

1.4

84.35

179.62

pmol/l

1.90

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

175

1353

0.82

1.91

1.3

227.34

196.66

pmol/l

0.23

175

1353

Thyroiditis

2.06

1.90

1.8

1.3

130.59

144.45

pmol/l

0.19

Disorders of ocular muscles, binocular movement, accommodation and refraction

193

1578

1.21

1.90

1.3

178.23

179.98

pmol/l

0.05

193

1578

Second line medication for Crohn's disease

174

2121

0.82

1.90

1.3

151.86

190.52

pmol/l

1.97

174

2121

COPD-related respiratory insufficiency

240

0.46

1.89

1.3

1.4

126.68

193.23

pmol/l

0.74

240

Malignant neoplasm of brain, including Hilmo

155

0.39

1.89

1.5

1.4

70.40

231.99

pmol/l

—

155

Amputation of ankle bones

0.00

1.89

0.0

1.5

—

150.06

—

Lung diseases due to external agents

319

0.53

1.88

1.4

108.04

191.07

pmol/l

1.59

319

Personal history of malignant neoplasm

0.00

1.88

0.0

1.2

—

141.09

—

Pruritus

143

1.75

1.88

1.3

143.32

156.46

pmol/l

0.20

143

Menorrhagia

2.29

1.88

1.1

1.0

9.90

12.31

pmol/l

0.53

Visual disturbances and blindness

179

1467

1.22

1.88

1.5

1.3

161.02

175.34

pmol/l

0.74

179

1467

Conjunctivitis

319

2294

1.16

1.88

1.4

1.3

176.91

193.12

pmol/l

0.62

319

2294

ILD medications: azathioprine

591

0.66

1.87

1.5

1.4

159.73

195.95

pmol/l

0.92

591

Male infertility

484

1.40

1.86

1.5

1.3

190.77

214.15

pmol/l

0.41

484

L04AX Other immunosuppressants

165

2017

0.82

1.86

1.3

152.90

190.77

pmol/l

1.77

165

2017

Pedal cyclist injured in collision with motor vehicle

1.99

1.85

1.2

1.5

183.74

172.32

pmol/l

0.13

Pediculosis, acariasis and other infestations

264

0.49

1.85

1.9

1.4

159.32

202.95

pmol/l

0.43

264

Tumor necrosis factor alpha inhibitors

637

0.67

1.85

1.3

157.56

191.23

pmol/l

0.90

637

Thyrotoxicosis with toxic multinodular goitre

2.40

1.85

1.1

1.2

120.32

135.37

pmol/l

0.18

Other viral diseases

191

1567

1.21

1.85

1.3

155.29

202.44

pmol/l

1.80

191

1567

Diaphragmatic hernia

101

776

1.30

1.84

1.3

1.4

154.60

178.10

pmol/l

0.87

101

776

Problems related to lifestyle

491

0.63

1.83

1.2

1.3

138.30

174.02

pmol/l

0.98

491

Persons encountering health services for examination and investigation

382

1666

1.15

1.83

1.4

1.3

195.46

199.37

pmol/l

0.05

382

1666

Heterophoria

175

1.66

1.82

1.1

1.3

134.25

160.24

pmol/l

0.60

175

Other specified/unspecified inflammatory spondylopathies

130

1.78

1.81

1.3

1.4

157.88

163.78

pmol/l

0.09

130

Sudden idiopathic hearing loss

238

1.56

1.81

1.5

1.4

145.86

203.75

pmol/l

0.78

238

569

1.34

1.81

1.2

1.4

156.29

176.03

pmol/l

0.46

569

Macular pucker

238

1.56

1.81

1.5

1.4

170.54

188.99

pmol/l

0.18

238

Localized swelling, mass and lump of skin and subcutaneous tissue

115

902

1.28

1.80

1.3

175.76

178.21

pmol/l

0.04

115

902

AV-block

397

0.62

1.80

1.7

1.4

166.65

187.91

pmol/l

0.30

397

Fasciculation

2.79

1.80

1.6

1.2

135.00

178.64

pmol/l

—

Suppurative and necrotic conditions of lower respiratory tract

167

0.42

1.78

1.0

1.5

222.53

224.01

pmol/l

—

167

Female genital prolapse

3.30

1.78

1.1

1.0

21.00

9.79

pmol/l

—

Polyarthropathies

227

1758

0.84

1.78

1.4

1.3

148.63

194.84

pmol/l

2.26

227

1758

Nontoxic goitre/thyroid nodule

255

1.53

1.77

1.2

1.4

150.97

182.79

pmol/l

0.37

255

Cerebral cysts

146

1.72

1.77

1.4

1.3

103.62

167.88

pmol/l

2.49

146

Benign paroxysmal vertigo

496

1.37

1.76

1.2

1.4

165.23

178.31

pmol/l

0.23

496

Dermatographic urticaria

102

1.87

1.76

1.1

1.4

194.28

156.64

pmol/l

0.69

102

Nontoxic single thyroid nodule

2.09

1.76

1.1

1.2

180.42

146.09

pmol/l

0.50

Pain (limb, back, neck, head abdominally)

419

1844

1.14

1.75

1.5

1.3

194.53

196.17

pmol/l

0.02

419

1844

Transplanted organ and tissue status

399

0.60

1.75

1.7

1.4

83.68

171.66

pmol/l

3.86

399

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

172

1417

1.22

1.75

1.4

1.3

170.69

206.01

pmol/l

0.99

172

1417

Colonic or urogenital fistula

114

897

1.27

1.75

1.4

168.62

178.13

pmol/l

0.27

114

897

Azathioprine

581

0.67

1.74

1.5

1.4

159.73

194.47

pmol/l

0.86

581

Malignant neoplasm of testis, including Hilmo

125

1.78

1.73

1.3

130.89

192.48

pmol/l

1.17

125

Other shoulder lesions

273

1.51

1.73

1.5

1.3

130.55

166.43

pmol/l

1.42

273

Paroxysmal tachycardia

770

0.74

1.73

1.4

1.3

162.19

177.87

pmol/l

0.64

770

Female infertility, associated with anovulation

2.67

1.72

1.1

1.0

11.36

12.61

pmol/l

—

Idiopathic gout

283

0.53

1.72

1.9

1.4

110.21

201.84

pmol/l

1.65

283

Myocardial infarction, with ST-elevation

507

0.65

1.72

1.2

1.4

146.79

179.56

pmol/l

0.73

507

Abdominal and pelvic pain

566

2548

1.12

1.72

1.4

1.3

169.58

192.06

pmol/l

1.23

566

2548

Other disorders of bone

715

1.30

1.71

1.2

1.3

159.06

179.40

pmol/l

0.63

715

Arthrosis

351

1677

1.15

1.71

1.4

1.3

189.06

194.55

pmol/l

0.07

351

1677

Recurrent dislocation and subluxation of joint

274

1.50

1.71

1.4

1.3

150.93

184.43

pmol/l

1.04

274

Collagenous colitis

163

1.66

1.71

1.8

1.4

178.27

160.47

pmol/l

0.25

163

Biological medication for rheuma

731

0.71

1.71

1.3

155.40

190.09

pmol/l

1.09

731

Hyperprolactinaemia

2.30

1.70

1.4

107.00

161.17

pmol/l

1.04

Other symptoms and signs involving the digestive system and abdomen

210

1.57

1.70

1.5

1.3

201.94

203.35

pmol/l

0.01

210

Diseases of appendix

367

2906

1.14

1.68

1.4

1.3

172.63

184.83

pmol/l

0.57

367

2906

Other and unspecified mental retardation

0.00

1.68

0.0

1.4

—

194.46

—

Disorders of acoustic nerve

2.20

1.68

1.6

1.3

166.51

179.73

pmol/l

0.14

Spermatocele

333

1.45

1.67

1.5

1.3

185.70

193.84

pmol/l

0.10

333

Effects of foreign body entering through natural orifice

109

1374

0.79

1.67

1.3

169.56

186.30

pmol/l

0.39

109

1374

Endocrine, nutritional and metabolic diseases

487

2196

1.12

1.67

1.5

1.3

176.00

189.89

pmol/l

0.32

487

2196

Bacterial, viral and other infectious agents

468

1.37

1.66

1.3

1.4

170.03

192.54

pmol/l

0.46

468

Other protozoal intestinal diseases

2.60

1.66

1.9

1.5

188.88

181.38

pmol/l

—

Appendicitis, broad definition

365

2903

1.14

1.66

1.4

1.3

172.37

184.80

pmol/l

0.58

365

2903

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

309

1.46

1.65

1.4

1.3

150.23

185.79

pmol/l

1.26

309

Other disorders of ear

390

2251

1.13

1.64

1.4

1.3

159.50

176.66

pmol/l

1.77

390

2251

Retention of urine

906

0.77

1.63

1.5

1.3

143.24

178.55

pmol/l

1.48

906

Respiratory insufficiency

148

0.40

1.63

1.5

1.3

79.55

239.47

pmol/l

—

148

Motorcycle rider injured in noncollision transport accidents

166

1.64

1.62

1.2

1.4

163.14

225.69

pmol/l

0.55

166

Malignant neoplasm of rectum, including Hilmo

315

0.57

1.61

1.2

1.4

202.92

198.89

pmol/l

0.04

315

Injuries to the head

527

2909

1.11

1.61

1.4

1.3

184.82

184.49

pmol/l

0.01

527

2909

Other erythematous conditions

2.15

1.61

1.2

1.4

156.38

172.78

pmol/l

0.18

Congenital malformations of eye, ear, face and neck

166

1.63

1.61

1.3

181.09

229.53

pmol/l

0.38

166

Non-seminoma of testis

3.12

1.60

1.3

1.6

84.68

216.06

pmol/l

—

Malignant neoplasm of rectum

237

0.50

1.60

1.2

1.3

196.71

203.92

pmol/l

0.06

237

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

120

855

1.25

1.60

1.2

1.3

190.60

201.66

pmol/l

0.26

120

855

Stenosis and insufficiency of lacrimal passages

113

1.77

1.60

1.3

1.4

159.44

147.55

pmol/l

0.20

113

Symptoms and signs involving cognition, perception, emotional state and behaviour

342

2653

0.88

1.60

1.4

1.3

144.72

187.07

pmol/l

3.35

342

2653

Erectile dysfunction

246

1.51

1.60

1.5

142.59

203.53

pmol/l

0.85

246

Presbyopia

198

1.57

1.59

1.2

1.4

228.98

209.53

pmol/l

0.10

198

Other salmonella infections

2.01

1.59

2.1

1.3

87.36

157.84

pmol/l

2.30

Abnormal findings on diagnostic imaging of central nervous system

106

1.80

1.59

1.2

1.4

175.93

165.62

pmol/l

0.12

106

Ehlers-Danlos syndrome

3.02

1.58

1.7

1.1

65.23

184.65

pmol/l

—

Family history of other specific disorders

3.02

1.58

1.2

215.00

209.07

pmol/l

—

Other skin changes

354

1.41

1.57

1.3

1.4

138.77

188.57

pmol/l

1.01

354

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

259

1113

1.17

1.57

1.4

1.3

198.91

193.86

pmol/l

0.05

259

1113

Mental and behavioural disorders due to sedatives or hypnotics

312

0.57

1.57

1.3

1.4

135.67

205.69

pmol/l

0.98

312

Other and unspecified erythematous conditions

2.21

1.57

1.3

1.4

160.77

178.20

pmol/l

0.17

Malignant neoplasm of prostate

129

952

0.81

1.57

1.4

1.3

117.37

179.76

pmol/l

5.34

129

952

Cyst of kidney

152

1.65

1.56

1.9

1.4

173.40

214.67

pmol/l

0.28

152

therapeutic use

2.28

1.55

2.0

1.2

88.34

162.10

pmol/l

—

Statin medication

313

2013

0.87

1.55

1.3

177.51

198.66

pmol/l

0.29

313

2013

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

247

0.52

1.55

1.2

1.4

189.42

204.43

pmol/l

0.14

247

Acute pharyngitis

747

1.28

1.55

1.3

173.85

190.21

pmol/l

0.48

747

Hypermetropia

160

1.63

1.55

1.3

1.4

196.19

227.12

pmol/l

0.21

160

Malignant neoplasm of testis

115

1.76

1.54

1.3

128.06

194.83

pmol/l

1.19

115

Anankastic personality disorder

100

1.81

1.53

1.1

1.4

169.64

165.25

pmol/l

0.06

100

Acute appendicitis

348

2871

1.13

1.53

1.4

1.3

170.89

184.94

pmol/l

0.67

348

2871

Postviral fatigue syndrome

3.37

1.53

1.4

1.1

98.18

180.79

pmol/l

—

Ehlers-Danlos syndrome

3.36

1.53

1.8

1.1

76.68

197.52

pmol/l

—

Bicipital tendinitis

169

1.61

1.52

1.8

1.3

167.27

168.33

pmol/l

0.01

169

Malignant neoplasm of head and neck

245

0.53

1.52

1.2

1.4

159.52

208.86

pmol/l

0.53

245

Delivery

0.44

1.51

1.0

1.1

11.26

36.22

pmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

2.18

1.51

1.3

1.4

179.86

208.60

pmol/l

0.30

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

179

0.49

1.50

1.4

1.3

275.24

191.97

pmol/l

—

179

Superficial injury of head

839

0.75

1.50

1.3

193.42

188.23

pmol/l

0.06

839

Abnormal spermatozoa

460

1.35

1.50

1.6

1.4

130.03

188.37

pmol/l

1.79

460

Adenocarcinoma and papilloma adenocarcinoma of rectum

231

0.52

1.50

1.2

1.4

184.21

204.49

pmol/l

0.19

231

Clear cell adenocarcinoma of kidney

125

0.40

1.50

1.6

1.5

104.58

227.21

pmol/l

—

125

Normal-pressure hydrocephalus

0.00

1.50

0.0

1.2

—

150.02

—

Hernia of abdominal wall, postoperative

590

1.31

1.49

1.2

1.3

170.95

193.86

pmol/l

0.46

590

Diseases of the eye and adnexa

491

2208

1.11

1.49

1.4

1.3

168.61

183.85

pmol/l

1.60

491

2208

Benign neoplasm: Other and unspecified parts of mouth

2.01

1.49

1.0

1.2

168.09

178.11

pmol/l

0.14

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.07

1.49

1.0

1.2

9.21

14.48

pmol/l

1.36

Certain infectious and parasitic diseases

365

1613

1.13

1.49

1.4

1.3

190.14

198.00

pmol/l

0.10

365

1613

Other noninfective gastroenteritis and colitis

660

1.29

1.49

1.5

1.3

155.57

186.55

pmol/l

0.95

660

Nasal polyp

661

1.29

1.48

1.3

467.56

184.99

pmol/l

0.45

661

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

344

2492

0.88

1.48

1.3

194.26

181.31

pmol/l

0.18

344

2492

Other infective otitis externa

139

1.66

1.48

2.0

1.4

147.88

233.08

pmol/l

0.64

139

Ischemic heart diseases

315

2153

0.88

1.48

1.4

1.3

159.24

189.02

pmol/l

1.43

315

2153

Cholelithiasis, broad definition with cholecystitis

218

1712

0.86

1.47

1.3

151.32

168.38

pmol/l

1.16

218

1712

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

2.59

1.47

1.1

1.6

158.41

227.69

pmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

2.25

1.47

1.3

1.4

195.23

207.61

pmol/l

—

Coronary revascularization (ANGIO or CABG)

298

2082

0.88

1.47

1.4

1.3

157.02

189.33

pmol/l

1.56

298

2082

Adjustment and management of implanted device

416

0.65

1.46

1.2

1.4

177.01

188.21

pmol/l

0.16

416

Other diseases of the respiratory system

452

0.66

1.46

1.4

121.05

184.07

pmol/l

1.78

452

Other respiratory disorders and diseases

452

0.66

1.46

1.4

121.05

184.07

pmol/l

1.78

452

N06DA Anticholinesterases

281

0.62

1.46

1.0

1.4

97.03

147.36

pmol/l

1.46

281

Use of anticholinesterases

281

0.62

1.46

1.0

1.4

97.03

147.36

pmol/l

1.46

281

Mood [affective] disorders

499

2916

1.11

1.46

1.4

1.3

157.63

189.55

pmol/l

2.30

499

2916

Emergency coronary revascularization (for ACS)

309

2138

0.88

1.46

1.4

1.3

157.19

188.20

pmol/l

1.52

309

2138

Bacterial, viral and other infectious agents

454

1.35

1.46

1.3

1.4

167.65

192.32

pmol/l

0.49

454

Arteriovenous malformation of cerebral vessels

2.53

1.46

1.1

1.3

186.96

176.08

pmol/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

2.53

1.46

1.1

1.2

241.86

186.83

pmol/l

—

Other specified and unspecified strabismus

2.52

1.45

1.1

1.2

106.27

192.09

pmol/l

—

ILD differential diagnosis

412

1838

1.12

1.45

1.4

1.3

162.14

184.95

pmol/l

2.44

412

1838

Postprocedural endocrine and metabolic disorders, not elsewhere classified

179

1.57

1.45

1.3

1.4

126.62

222.46

pmol/l

1.05

179

Hypospadias

3.20

1.45

1.4

1.1

281.40

214.87

pmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

117

1.72

1.45

1.5

1.4

179.39

181.73

pmol/l

0.02

117

Alzheimer’s disease (Late onset)

129

0.46

1.44

1.0

1.3

166.70

140.52

pmol/l

—

129

General examination and investigation of persons without complaint and reported diagnosis

361

1666

1.13

1.44

1.4

1.3

184.73

199.37

pmol/l

0.20

361

1666

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

132

0.46

1.44

1.0

1.1

9.34

26.36

pmol/l

—

132

Bipolar affective disorders

726

1.27

1.44

1.3

150.46

185.66

pmol/l

1.04

726

Migraine

146

980

1.21

1.43

1.5

1.3

144.68

181.12

pmol/l

3.28

146

980

Excluding asthma or asthma-COPD overlap

415

1854

1.12

1.43

1.4

1.3

161.87

185.06

pmol/l

2.52

415

1854

Spasmodic torticollis

2.32

1.43

1.7

1.2

164.42

157.74

pmol/l

—

Other disorders starting during childhood or adolescence

153

0.45

1.42

1.6

1.3

265.17

201.00

pmol/l

—

153

Mood disorders

499

2916

1.11

1.42

1.4

1.3

157.63

189.55

pmol/l

2.30

499

2916

Spondylopathies (FG)

534

1.31

1.42

1.2

1.3

166.33

175.77

pmol/l

0.30

534

Other and unspecified effects of external causes

118

960

1.23

1.42

1.3

143.84

189.08

pmol/l

2.99

118

960

Other specified/unspecified disorders of bone/cartilage

1.83

1.42

1.4

1.5

169.16

280.34

pmol/l

0.53

Nontraumatic intracranial haemmorrhage

460

0.67

1.41

1.5

1.4

142.40

182.52

pmol/l

0.98

460

Other and unspecified polyneuropathies, also in other diseases

544

1.31

1.40

1.3

140.35

179.84

pmol/l

1.17

544

Tobacco use

178

0.50

1.40

1.3

1.5

136.63

215.33

pmol/l

—

178

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1231

0.80

1.39

1.3

207.24

183.19

pmol/l

0.88

1231

Other disorders of nervous system

178

0.50

1.39

1.3

1.4

91.10

215.84

pmol/l

—

178

COPD differential diagnosis

411

1839

1.12

1.39

1.4

1.3

162.10

184.95

pmol/l

2.44

411

1839

Hydrocele

536

1.31

1.39

1.3

176.61

190.60

pmol/l

0.29

536

Small fibre neuropathy

2.09

1.38

1.5

1.3

138.03

161.86

pmol/l

0.28

Diseases of liver

100

1241

0.80

1.38

1.4

1.3

138.22

179.13

pmol/l

2.60

100

1241

Nutritional anaemias

993

0.79

1.38

1.2

1.3

134.97

169.46

pmol/l

1.17

993

Sacroiliitis, not elsewhere classified

142

1.63

1.38

1.1

1.4

190.61

168.69

pmol/l

0.34

142

Single spontaneous delivery

0.45

1.38

1.0

1.1

12.24

36.22

pmol/l

—

Acute appendicitis, no complications

289

2531

1.14

1.38

1.4

1.3

172.25

187.26

pmol/l

0.63

289

2531

Epilepsy

1015

0.78

1.38

1.2

1.3

174.49

188.77

pmol/l

0.24

1015

Mixed connective tissue disease

2.00

1.38

1.4

1.2

110.23

137.91

pmol/l

0.57

Other diseases of lip and oral mucosa

137

1136

1.21

1.37

1.3

153.10

177.00

pmol/l

1.20

137

1136

Tramadol

368

2012

1.12

1.37

1.4

1.3

183.34

190.47

pmol/l

0.10

368

2012

Neurotic, stress-related and somatoform disorders

436

2744

1.11

1.37

1.4

1.3

181.80

188.10

pmol/l

0.10

436

2744

Diseases of salivary glands

106

857

1.24

1.36

1.2

1.3

168.86

176.99

pmol/l

0.22

106

857

Benign neoplasm of mouth and pharynx

281

1.43

1.35

1.2

1.4

172.78

193.57

pmol/l

0.25

281

Other inflammation of eyelid

281

1.43

1.35

1.5

1.4

162.20

193.72

pmol/l

0.38

281

Other and unspecified disorders of psychological development

0.00

1.35

0.0

1.4

—

222.20

—

Malignant neoplasm of colon

298

0.60

1.35

1.3

1.4

161.59

198.16

pmol/l

0.48

298

Alzheimer’s disease (Late onset), excluding more controls

101

0.45

1.35

1.0

1.5

166.70

168.47

pmol/l

—

101

Clubfoot

0.00

1.35

0.0

1.4

—

197.92

—

Brain glioblastoma

0.00

1.35

0.0

1.4

—

155.67

—

Impacted cerumen

191

1.52

1.34

1.8

1.4

154.05

216.33

pmol/l

0.55

191

Poisoning by medicine, drug-induced

0.00

1.34

0.0

1.3

—

167.23

—

Excessive attrition of teeth

238

2072

1.15

1.34

1.4

1.3

160.48

189.18

pmol/l

1.17

238

2072

Other misadventures during surgical and medical care

2.14

1.34

1.9

1.3

152.22

163.97

pmol/l

—

Periapical abscess

169

1987

0.85

1.34

1.4

1.3

158.34

193.07

pmol/l

1.40

169

1987

Redundant prepuce, phimosis and paraphimosis

207

1768

1.16

1.33

1.2

1.3

187.23

209.34

pmol/l

0.69

207

1768

Other articular cartilage disorders

2.05

1.33

1.8

1.2

156.78

184.76

pmol/l

0.51

Effects of other external causes

136

1.63

1.33

1.3

1.4

190.77

186.77

pmol/l

0.06

136

Other functional intestinal disorders

132

1015

1.21

1.33

1.4

1.3

151.32

181.54

pmol/l

1.47

132

1015

Other secondary coxarthrosis

1.98

1.33

1.1

1.2

136.70

159.45

pmol/l

0.32

Adenocarcinoma of pancreas

0.00

1.33

0.0

1.3

—

174.51

—

Invasive ventilation

208

0.53

1.32

1.9

1.4

156.77

209.51

pmol/l

0.44

208

Persons encountering health services in circumstances related to reproduction

374

2253

1.12

1.32

1.4

1.3

184.74

196.25

pmol/l

0.39

374

2253

Oral corticosteroids

420

2765

0.90

1.32

1.4

1.3

148.77

188.19

pmol/l

3.24

420

2765

Obsessive-compulsive disorder

233

1.46

1.31

1.3

176.78

178.00

pmol/l

0.02

233

Alcoholic gastritis

0.00

1.31

0.0

1.3

—

140.55

—

Scabies

207

0.53

1.31

2.0

1.4

135.20

168.93

pmol/l

0.44

207

Reimbursement for rheumatic diseases

140

1662

0.84

1.31

1.2

1.3

154.42

175.54

pmol/l

1.37

140

1662

Cramp and spasm

121

1.66

1.31

1.7

1.4

162.97

239.53

pmol/l

0.46

121

Klinefelter syndrome, karyotype 47 XXY

2.89

1.30

1.0

1.7

132.98

232.58

pmol/l

—

Other viral hepatitis

343

0.64

1.30

1.2

1.4

161.66

205.11

pmol/l

0.53

343

Other congenital malformations of face and neck

1.85

1.30

1.5

154.70

183.28

pmol/l

0.35

Appendectomy

298

2523

1.13

1.30

1.4

1.3

167.12

188.82

pmol/l

1.05

298

2523

Benign neoplasm: Testis

2.83

1.29

2.0

1.3

105.04

199.62

pmol/l

—

Hypo-osmolality and hyponatraemia

389

0.66

1.29

1.5

1.3

87.67

193.47

pmol/l

3.15

389

L02BA Anti-estrogens

2.35

1.29

1.1

1.2

208.14

83.82

pmol/l

—

Calcaneal spur

2.80

1.29

1.8

1.2

212.20

166.14

pmol/l

—

Vertigo of central origin

2.79

1.28

1.2

1.3

187.64

174.06

pmol/l

—

Persistent mood disorders

543

1.29

1.28

1.3

136.74

184.93

pmol/l

1.48

543

481

2252

1.10

1.28

1.4

1.3

158.99

181.58

pmol/l

2.94

481

2252

Delirium, not induced by alcohol and other psychoactive substances

243

0.57

1.28

1.3

1.4

157.86

199.80

pmol/l

0.43

243

Patellar tendinitis

1.80

1.28

1.4

205.95

179.08

pmol/l

0.30

Anisometropia and aniseikonia

2.09

1.28

1.3

172.15

186.95

pmol/l

—

Benign neoplasm: Cranial nerves

2.01

1.27

1.6

1.3

153.19

173.21

pmol/l

0.23

Other general symptoms and signs

1.72

1.27

1.3

185.67

175.36

pmol/l

0.10

Malignant melanoma, including Hilmo

413

0.68

1.27

1.2

1.4

189.72

188.10

pmol/l

0.02

413

Anxiety disorders

438

2761

1.11

1.26

1.4

1.3

182.19

188.02

pmol/l

0.09

438

2761

Atrial fibrillation and flutter

156

1194

0.85

1.26

1.4

1.3

165.43

181.24

pmol/l

1.20

156

1194

Syphilis

107

1.69

1.26

1.4

1.5

194.83

252.03

pmol/l

0.29

107

Syphilis

107

1.69

1.26

1.4

1.5

194.83

252.03

pmol/l

0.29

107

Hyperplasia of prostate

253

1256

1.15

1.26

1.5

1.3

155.17

175.11

pmol/l

1.24

253

1256

Open bite

107

1.69

1.25

1.1

1.2

152.07

177.28

pmol/l

0.43

107

Other and unspecified injuries of neck

2.42

1.25

1.3

1.2

197.28

173.23

pmol/l

—

Hydrocephalus

116

0.43

1.25

1.4

1.3

203.88

156.41

pmol/l

—

116

Malignant neoplasm of oesophagus, including Hilmo

118

0.42

1.25

1.4

1.5

87.70

241.26

pmol/l

—

118

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

146

1232

1.19

1.24

1.4

1.3

173.98

189.54

pmol/l

0.46

146

1232

Bruxism

2.41

1.24

1.2

135.42

182.84

pmol/l

—

Recurrent aphthous stomatitis , including avohilmo

320

1.38

1.24

1.4

162.13

195.62

pmol/l

0.50

320

Malignant neoplasm of pancreas, including Hilmo

158

0.51

1.24

1.0

1.4

135.66

169.24

pmol/l

—

158

Benign neoplasm: Skin of eyelid, including canthus

261

1.42

1.24

1.4

139.47

202.06

pmol/l

0.98

261

Volume depletion

203

0.54

1.24

1.3

1.4

91.25

179.46

pmol/l

1.85

203

Other sexually transmitted chlamydial diseases

270

1.41

1.23

1.4

1.3

205.56

178.63

pmol/l

0.75

270

Malignant neoplasm of urinary organs

253

0.59

1.23

1.5

1.4

150.92

207.53

pmol/l

0.70

253

Asthma mixed form (mode), excluding more controls

100

1.70

1.23

1.3

161.01

281.73

pmol/l

0.68

100

Alcohol-induced chronic pancreatitis

338

0.65

1.23

1.2

1.4

200.96

198.63

pmol/l

0.02

338

Diabetic retinopathy, excluding more controls

375

0.75

1.22

1.4

1.5

117.77

155.09

pmol/l

0.73

375

Enteropathic arthropathies

2.05

1.22

1.3

143.17

171.06

pmol/l

—

malignant neoplasm of male genital organs

149

1072

0.85

1.22

1.3

121.10

180.87

pmol/l

5.43

149

1072

Other disorders of glucose regulation and pancreatic internal secretion

252

0.59

1.22

1.3

1.4

280.43

208.51

pmol/l

0.24

252

Lateral epicondylitis

425

1.32

1.21

1.5

1.3

152.33

166.89

pmol/l

0.42

425

Psychiatric diseases

503

2295

1.10

1.21

1.3

180.26

191.41

pmol/l

0.21

503

2295

Postpartum haemorrhage due to retained placenta

2.16

1.21

1.0

1.1

8.83

11.28

pmol/l

—

Bilateral sagittal split ramus osteotomy operation

1.80

1.21

1.1

1.4

227.40

160.96

pmol/l

1.61

Malignant melanoma

337

0.65

1.21

1.2

1.4

195.91

195.65

pmol/l

0.00

337

Pregnancy hypertension

129

0.49

1.21

1.0

1.1

9.34

26.55

pmol/l

—

129

Mood disorders, excluding more controls

467

2535

1.10

1.20

1.3

159.36

189.28

pmol/l

1.85

467

2535

Asthma/COPD (KELA code 203)

385

2921

0.90

1.20

1.3

164.84

188.36

pmol/l

1.43

385

2921

Focal epilepsy

695

0.76

1.20

1.2

1.3

199.91

184.29

pmol/l

0.16

695

Stomatitis and related lesions

549

1.28

1.20

1.5

1.3

153.88

183.19

pmol/l

0.73

549

Other diseases of pleura

108

1145

0.83

1.20

1.4

150.01

171.75

pmol/l

0.88

108

1145

Asthma mixed form (mode)

101

1.69

1.19

1.3

161.01

280.56

pmol/l

0.68

101

Inguinal hernia

412

2494

1.11

1.19

1.3

1.4

237.94

182.94

pmol/l

0.42

412

2494

Zoster [herpes zoster]

139

1155

1.19

1.18

1.5

1.4

168.61

173.12

pmol/l

0.14

139

1155

Other deformities of toe(s)

2.11

1.18

1.6

1.2

172.29

156.92

pmol/l

—

Ill-defined and unknown causes of mortality

168

0.53

1.18

1.2

1.5

161.02

165.72

pmol/l

—

168

Other diseases of biliary tract

170

0.53

1.18

1.3

1.4

214.97

218.37

pmol/l

—

170

Sequelae of injuries of lower limb

341

1.35

1.17

1.3

1.4

175.40

200.26

pmol/l

0.36

341

Acute gastritis

173

1.51

1.17

1.2

1.4

176.90

211.53

pmol/l

0.27

173

Aortic valve malfunction, age under 60 years

475

0.71

1.17

1.2

1.4

130.73

188.89

pmol/l

1.68

475

Exposure to uncontrolled fire in building or structure

0.00

1.17

0.0

1.3

—

176.66

—

Varicella [chickenpox]

265

1.40

1.17

1.6

1.4

167.88

206.60

pmol/l

0.50

265

Conduction disorders

726

0.79

1.16

1.5

1.3

157.86

177.87

pmol/l

0.58

726

Malignant neoplasm of oral cavity, including Hilmo

128

0.47

1.16

1.5

159.60

239.08

pmol/l

—

128

Medical treatment for female infertility

1.73

1.16

1.2

1.1

8.15

11.84

pmol/l

1.52

Unspecified visual impairment (binocular)

0.00

1.16

0.0

1.2

—

175.44

—

Malignant neoplasm of eye and adnexa, including Hilmo

0.00

1.16

0.0

1.2

—

174.98

—

Percutaneous Coronary Intervention

303

2079

0.89

1.16

1.4

1.3

156.44

189.24

pmol/l

1.59

303

2079

Small cell lung cancer, including Hilmo

0.00

1.16

0.0

1.3

—

167.17

—

Small cell lung cancer

0.00

1.16

0.0

1.3

—

167.17

—

Toxic effect of other gases, fumes and vapours

2.53

1.15

1.6

1.2

119.74

162.76

pmol/l

—

GASTRO-related operations

425

1932

1.10

1.15

1.3

164.87

190.82

pmol/l

3.11

425

1932

Any gastric operation

425

1932

1.10

1.15

1.3

164.87

190.82

pmol/l

3.11

425

1932

Deforming dorsopathies

776

1.23

1.15

1.6

1.3

159.60

168.82

pmol/l

0.40

776

Varicose veins

106

967

0.83

1.15

1.3

1.4

152.16

159.49

pmol/l

0.32

106

967

Other disorders of bladder

325

1.36

1.15

1.3

1.4

149.77

196.88

pmol/l

0.85

325

Other diseases of pancreas

223

0.58

1.15

1.1

1.5

168.38

208.46

pmol/l

0.29

223

Other diseases of anus and rectum

748

1.23

1.14

1.6

1.3

136.45

179.37

pmol/l

1.73

748

Diseases of the respiratory system

271

1202

1.13

1.4

1.3

159.32

186.65

pmol/l

1.92

271

1202

Other diseases of gallbladder

1.90

1.12

1.6

1.4

156.71

151.52

pmol/l

0.05

Chondropathies

546

1.27

1.12

1.2

1.3

155.30

185.37

pmol/l

0.83

546

Migraine without aura

362

1.33

1.11

1.3

123.69

167.56

pmol/l

1.68

362

Contact with machinery

601

1.25

1.10

1.1

1.3

153.82

190.94

pmol/l

1.19

601

Routine general health check-up of defined subpopulation

2.27

1.10

1.7

1.3

179.30

167.85

pmol/l

—

Any event in hilmo or specialist outpatient

2.16

1.10

1.2

196.09

216.50

pmol/l

—

Single delivery by caesarean section

0.48

1.10

1.0

1.1

8.82

39.09

pmol/l

—

Other disorders starting during childhood or adolecense, excluding more controls

131

0.51

1.10

1.6

1.4

265.17

213.29

pmol/l

—

131

Iron deficiency anaemia secondary to blood loss (chronic)

281

0.64

1.10

1.4

143.59

195.11

pmol/l

0.66

281

Carcinoma in situ of prostate

2.41

1.09

1.0

1.3

259.60

158.27

pmol/l

—

Postzoster neuralgia

2.39

1.09

1.4

1.2

142.66

156.30

pmol/l

—

Endometriosis of pelvic peritoneum

2.22

1.09

1.1

1.0

6.49

12.83

pmol/l

—

Candidiasis

277

1.37

1.09

1.2

1.4

166.28

191.04

pmol/l

0.27

277

Disorders of puberty, all

1.96

1.09

1.0

1.1

111.18

211.82

pmol/l

—

Neoplasms

487

2364

1.09

1.4

1.3

171.08

196.58

pmol/l

1.30

487

2364

Urethritis and urethral syndrome

1.96

1.09

1.1

1.2

220.30

171.99

pmol/l

—

Injuries to the neck

105

874

1.20

1.08

1.4

1.3

179.76

181.10

pmol/l

0.03

105

874

Secondary uncertain malignant neoplasm

339

0.68

1.07

1.1

1.4

124.73

205.37

pmol/l

1.75

339

Mandibular retrognathia AND surgery (BSSO)

1.87

1.07

1.1

1.3

229.15

164.59

pmol/l

1.12

Glomerulonephritis

315

0.66

1.07

1.3

1.4

180.89

195.90

pmol/l

0.17

315

Spondyloarthritis

630

1.24

1.07

1.2

1.4

166.24

187.12

pmol/l

0.55

630

Other and/or unspecified nontoxic goitre

1.87

1.07

1.3

1.2

147.95

144.92

pmol/l

0.03

Polyarthritis, unspecified

1.76

1.07

1.4

1.2

179.69

159.76

pmol/l

0.33

Nausea and vomiting

624

0.77

1.06

1.2

1.3

193.11

179.59

pmol/l

0.12

624

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.93

1.06

1.1

1.4

167.48

174.48

pmol/l

—

Hypertrophic disorders of skin

105

1.62

1.06

1.4

1.3

141.71

157.82

pmol/l

0.21

105

Perichondritis of external ear

2.13

1.06

2.0

1.3

131.14

170.51

pmol/l

—

Type of accident

1101

0.83

1.05

1.3

206.42

182.29

pmol/l

0.80

1101

Injury of urinary and pelvic organs

1.80

1.05

1.6

1.3

182.03

172.00

pmol/l

0.10

Viral infections characterized by skin and mucous membrane lesions

185

1616

1.14

1.05

1.4

1.3

166.64

178.13

pmol/l

0.57

185

1616

Malignant neoplasm of skin

114

928

0.84

1.05

1.2

1.4

167.97

177.83

pmol/l

0.32

114

928

Other abnormal auditory perceptions

2.29

1.03

1.0

1.2

162.26

171.30

pmol/l

—

Panic disorder

490

1.27

1.03

1.4

1.3

164.42

171.53

pmol/l

0.18

490

Chronic ulcer of skin, not elsewhere classified

147

0.54

1.03

1.0

1.4

129.33

232.24

pmol/l

—

147

Other ill-defined and unspecified causes of mortality

147

0.54

1.03

1.1

1.4

172.40

164.54

pmol/l

—

147

Disease of hard tissues of teeth, NOS

286

1339

1.12

1.03

1.4

1.3

191.84

179.85

pmol/l

0.15

286

1339

Melanocytic naevi of scalp and neck

1.84

1.03

2.5

1.5

203.96

179.37

pmol/l

0.40

Non-invasive ventilation

892

0.82

1.02

1.3

160.97

184.23

pmol/l

1.18

892

Acute lymphadenitis

196

1.43

1.02

1.1

1.3

170.65

214.64

pmol/l

0.42

196

Cardiac murmurs and other cardiac sounds

169

1.46

1.02

1.4

170.68

183.77

pmol/l

0.22

169

Disorder of the sleep-wake schedule

1.90

1.01

1.1

1.4

148.35

184.94

pmol/l

—

Spondylolisthesis/Spondylolysis

474

1.27

1.01

1.5

1.3

160.46

166.64

pmol/l

0.19

474

Hordeolum and other deep inflammation of eyelid

155

1.49

1.01

1.3

1.4

185.03

212.34

pmol/l

0.17

155

Foreign body in respiratory tract

108

0.46

1.00

1.4

130.84

162.02

pmol/l

—

108

Diseases of the skin and subcutaneous tissue

513

2372

1.09

1.00

1.3

168.14

193.44

pmol/l

1.32

513

2372

Fracture of forearm

139

1478

0.86

1.00

1.3

181.63

185.12

pmol/l

0.08

139

1478

Triptan medication for migraine, min. 3 purchases

169

1122

1.15

1.00

1.3

144.13

175.18

pmol/l

1.84

169

1122

Benign neoplasm: Caecum

180

1.45

1.00

1.3

1.4

207.45

202.15

pmol/l

0.03

180

Open wound of abdomen, lower back and pelvis

110

0.45

1.00

1.0

1.3

186.48

173.44

pmol/l

—

110

Benign neoplasm: Sigmoid colon

448

1.27

1.00

1.4

1.3

176.29

182.05

pmol/l

0.08

448

Duodenal ulcer

250

0.64

1.00

1.4

184.55

198.75

pmol/l

0.12

250

Transient ischemic attack

119

1132

0.85

1.00

1.3

1.4

138.63

172.87

pmol/l

2.15

119

1132

Acute laryngitis and tracheitis

564

1.24

0.99

1.4

1.3

204.23

213.99

pmol/l

0.17

564

Wide developmental disorders, excluding more controls

129

1.53

0.99

1.2

1.4

102.54

193.26

pmol/l

2.21

129

Use of memantine

177

0.61

0.99

1.2

1.3

106.29

145.43

pmol/l

0.75

177

Use of other anti-dementia drugs

177

0.61

0.99

1.2

1.3

106.29

145.43

pmol/l

0.75

177

Disorders of iron metabolism

1.85

0.99

1.2

1.6

269.38

182.53

pmol/l

—

Suggestive for eosinophilic asthma

274

1.35

0.99

1.4

165.11

204.21

pmol/l

0.54

274

Other disorders of Eustachian tube

1.84

0.98

1.3

160.07

175.54

pmol/l

—

Scarlet fever

2.19

0.98

1.0

1.3

134.70

197.11

pmol/l

—

Thyrotropin deficiency

2.19

0.98

1.6

1.3

110.10

168.88

pmol/l

—

Lung transplant status

0.00

0.98

0.0

1.3

—

163.15

—

Lung transplantation

0.00

0.98

0.0

1.3

—

163.15

—

Unspecified privation

320

0.69

0.98

1.6

1.4

155.75

197.37

pmol/l

0.65

320

Benign neoplasm: Adrenal gland

159

0.56

0.98

1.0

1.5

94.70

219.94

pmol/l

—

159

Other special examinations and investigations of persons without complaint or reported diagnosis

362

1666

1.10

0.98

1.4

1.3

174.24

199.37

pmol/l

0.86

362

1666

Other diseases of the digestive system

949

0.82

0.98

1.4

181.68

174.83

pmol/l

0.09

949

Tooth eruption problems

447

1.27

0.98

1.2

1.4

197.64

178.15

pmol/l

0.58

447

Alcohol induced polyneuropathy

0.00

0.97

0.0

1.3

—

163.68

—

Adalimumab

366

0.71

0.97

1.4

154.75

197.66

pmol/l

0.71

366

Disorders of puberty

1.95

0.97

1.0

1.1

83.63

225.55

pmol/l

—

Conjunctivitis (acute, non atopic)

106

891

1.19

0.97

1.3

157.65

179.93

pmol/l

0.83

106

891

Other condition

537

0.76

0.96

1.5

1.3

180.17

192.45

pmol/l

0.19

537

Complications of internal orthopaedic prosthetic devices, implants and grafts

415

1.28

0.96

1.4

131.82

187.08

pmol/l

1.32

415

Secondary malignant neoplasm of respiratory and digestive organs

0.00

0.96

0.0

1.3

—

172.19

—

Etanercept

174

0.57

0.96

1.1

1.4

200.12

222.84

pmol/l

—

174

Intestinal stricture

804

0.81

0.96

1.2

1.3

164.10

177.14

pmol/l

0.30

804

Depression

460

2873

1.09

0.96

1.3

155.72

190.22

pmol/l

2.56

460

2873

Astigmatism

165

1.46

0.96

1.5

1.4

166.69

174.05

pmol/l

0.11

165

Diseases of external ear

126

1080

1.17

0.95

1.6

1.3

144.19

178.34

pmol/l

1.69

126

1080

Viral hepatitis

376

0.72

0.95

1.2

1.4

164.00

202.45

pmol/l

0.51

376

Crushed, pushed or stepped on by crowd or human stampede

372

1.29

0.95

1.2

1.4

194.94

206.49

pmol/l

0.16

372

Intracranial trauma

276

1747

1.11

0.95

1.4

1.3

174.26

189.30

pmol/l

0.87

276

1747

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

0.00

0.95

0.0

1.2

—

152.79

—

Desensitization to allergens

174

1.44

0.95

1.2

1.3

177.54

179.06

pmol/l

0.02

174

Influenza and pneumonia

435

3001

0.92

0.94

1.4

1.3

160.36

189.15

pmol/l

1.91

435

3001

Asthma and opportunity respiratory infection

1.77

0.94

1.3

1.2

131.76

171.20

pmol/l

—

Explicit bacterial Sepsis

317

0.69

0.94

1.4

181.75

201.67

pmol/l

0.22

317

Amblyopia ex anopsia

1.65

0.94

1.5

1.2

180.79

186.41

pmol/l

0.06

Struck by thrown, projected or falling objec

234

1.37

0.93

1.4

145.40

210.86

pmol/l

0.90

234

Intussusception

2.23

0.93

1.0

1.5

243.17

179.56

pmol/l

—

Nontoxic diffuse goitre

2.23

0.93

1.3

1.1

112.18

152.27

pmol/l

—

Melanocytic naevi of other and unspecified parts of face

101

1.59

0.93

2.2

1.4

228.15

157.29

pmol/l

0.68

101

Cholecystectomy

184

1399

1.13

0.93

1.3

154.43

168.03

pmol/l

0.69

184

1399

Malignant neoplasm of stomach, including Hilmo

120

0.50

0.93

1.0

1.5

145.72

231.90

pmol/l

—

120

Thrombocytopenia, unspecified

172

0.58

0.93

1.7

1.4

130.16

219.47

pmol/l

—

172

Other and unspecified diseases of blood and blood-forming organs

1.83

0.92

1.4

1.3

134.11

172.75

pmol/l

—

Codes for special purposes

157

1788

0.88

0.92

1.4

1.3

154.25

191.48

pmol/l

1.44

157

1788

In situ neoplasms

476

0.76

0.91

1.2

1.4

148.36

163.60

pmol/l

0.26

476

Hypokalaemia

256

0.66

0.91

1.2

1.4

119.16

208.12

pmol/l

1.18

256

Malignant neoplasm of kidney, except renal pelvis

232

0.65

0.91

1.5

1.4

150.92

213.93

pmol/l

0.75

232

Other osteochondropathies

287

1.33

0.91

1.2

1.4

160.82

201.47

pmol/l

0.60

287

Cerebral palsy and other paralytic syndromes

303

0.69

0.91

1.4

137.78

193.60

pmol/l

0.85

303

Other/unspecified dorsalgia

132

1131

1.16

0.91

1.5

1.3

169.31

169.85

pmol/l

0.02

132

1131

Ptosis of eyelid

184

1.42

0.91

1.8

1.4

187.21

203.41

pmol/l

0.10

184

Injuries to the thorax

169

1916

0.88

0.91

1.3

153.50

179.06

pmol/l

1.91

169

1916

Varicella [chickenpox]

287

1.33

0.91

1.6

1.3

163.65

203.94

pmol/l

0.57

287

Injury of muscle and tendon at wrist and hand level

676

0.80

0.90

1.4

153.17

197.88

pmol/l

1.47

676

Embedded teeth, including avohilmo

296

1.32

0.90

1.2

1.4

183.15

174.02

pmol/l

0.19

296

Provisional assignment of new diseases of uncertain etiology

157

1785

0.88

0.90

1.4

1.3

154.25

191.56

pmol/l

1.44

157

1785

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

207

0.63

0.90

1.6

1.4

153.18

167.88

pmol/l

0.12

207

Other/unspecified enthesopathies, not elsewhere classified

210

1.38

0.90

1.2

1.3

150.92

165.82

pmol/l

0.35

210

Asthma-related pneumonia or sepsis

948

0.83

0.90

1.4

1.3

143.78

180.91

pmol/l

1.69

948

Asthma, hospital admissions 3, pneumonia

948

0.83

0.90

1.4

1.3

143.78

180.91

pmol/l

1.69

948

Oedema, not elsewhere classified

851

0.82

0.90

1.5

1.3

132.79

168.78

pmol/l

2.08

851

Iron deficiency anaemia

839

0.82

0.90

1.2

1.3

133.06

168.26

pmol/l

0.99

839

Ovarian cyst

1.63

0.89

1.0

1.1

8.29

12.79

pmol/l

1.13

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.08

0.89

1.7

1.1

65.23

178.89

pmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

312

2074

0.91

0.89

1.4

1.3

164.74

182.78

pmol/l

1.15

312

2074

312

2074

0.91

0.89

1.4

1.3

164.74

182.78

pmol/l

1.15

312

2074

Diverticular disease of intestine

269

1550

1.11

0.89

1.4

1.3

154.73

177.72

pmol/l

1.83

269

1550

Arterial embolism and thrombosis

102

0.49

0.89

1.0

1.4

125.04

167.11

pmol/l

—

102

Asthma-related pneumonia

947

0.83

0.89

1.4

1.3

143.78

180.83

pmol/l

1.68

947

Cholelithiasis

210

1621

0.89

1.3

151.71

168.58

pmol/l

1.08

210

1621

Loose body in joint

1.70

0.89

1.2

177.72

173.58

pmol/l

0.05

Retinal detachments and breaks

111

949

1.17

0.89

1.3

162.37

171.04

pmol/l

0.27

111

949

Somatoform disorder

403

1.27

0.88

1.2

1.4

155.62

165.98

pmol/l

0.18

403

Other gastritis (incl. Duodenitis)

585

0.79

0.88

1.2

1.3

190.44

181.18

pmol/l

0.17

585

Anxiety disorders, excluding more controls

406

2433

1.09

0.88

1.4

1.3

184.24

189.86

pmol/l

0.08

406

2433

Persons encountering health services in other circumstances, wide

515

2851

0.93

0.88

1.4

1.3

179.54

187.06

pmol/l

0.15

515

2851

Hyperaldosteronism

1.79

0.88

1.2

1.4

76.60

162.87

pmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

110

872

0.85

0.87

1.2

1.4

171.49

180.07

pmol/l

0.25

110

872

Disorders of calcium metabolism

130

0.54

0.87

1.3

1.5

164.07

243.99

pmol/l

—

130

Rheumatic fever incl heart disease

1.87

0.87

1.3

1.2

141.28

176.58

pmol/l

—

Migraine without aura and triptan purchases

263

1.33

0.87

1.3

116.17

177.75

pmol/l

0.89

263

Other ulcerative colitis

203

1.38

0.87

1.1

1.4

198.37

209.49

pmol/l

0.08

203

Inflammatory disease of uterus

1.86

0.87

1.0

1.1

11.70

14.05

pmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

206

1597

1.12

0.87

1.4

1.3

163.79

171.14

pmol/l

0.34

206

1597

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

180

0.61

0.86

1.6

1.5

156.88

213.55

pmol/l

0.48

180

Speech therapy

616

0.79

0.86

1.3

168.46

180.17

pmol/l

0.23

616

Polyp of the female genital tract

2.03

0.86

1.0

9.98

9.51

pmol/l

—

Mixed hyperlipidaemia

128

1.49

0.86

1.8

1.5

128.82

183.63

pmol/l

0.55

128

Subarachnoid haemorrhage

228

0.66

0.85

1.2

1.4

161.91

209.71

pmol/l

0.56

228

Maternal care for known or suspected abnormality of pelvic organs

0.52

0.85

1.0

1.1

8.15

38.35

pmol/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

492

0.77

0.85

1.2

1.4

131.36

189.29

pmol/l

1.81

492

Disorders of conjunctiva

341

2510

1.09

0.85

1.3

174.79

189.77

pmol/l

0.62

341

2510

Follow-up examination after treatment for malignant neoplasms

120

1.50

0.85

1.1

1.4

102.74

157.03

pmol/l

1.48

120

Abnormal findings on examination of blood, without diagnosis

158

1643

0.88

0.85

1.3

154.83

173.35

pmol/l

1.15

158

1643

Hereditary ataxia

1.95

0.84

1.2

1.3

133.07

154.13

pmol/l

—

Asymmetry of jaw

1.95

0.84

1.5

1.2

187.83

180.58

pmol/l

—

Reactive arthropathies

256

1.33

0.84

1.1

1.3

154.30

178.71

pmol/l

0.69

256

Intracerebral haemorrhage

251

0.68

0.84

1.8

1.5

129.46

202.40

pmol/l

1.07

251

Cutaneous abscess, furuncle and carbuncle

1148

0.85

0.84

1.3

140.41

185.91

pmol/l

2.66

1148

Atopic conjunctivitis

104

1.54

0.84

2.1

1.3

179.83

163.66

pmol/l

0.22

104

Mandibular prognathia

1.79

0.84

1.1

1.2

213.28

189.72

pmol/l

—

Urticaria and erythema

111

954

1.16

0.84

1.3

158.16

177.63

pmol/l

0.72

111

954

Hypertrophic scar

1.57

0.84

1.4

1.3

142.94

160.10

pmol/l

0.21

Disorders of vestibular function (Vertigo)

116

984

1.16

0.84

1.3

1.4

157.82

169.85

pmol/l

0.39

116

984

Other viral diseases, not elsewhere classified

667

1.20

0.84

1.3

149.76

190.57

pmol/l

1.39

667

Other peripheral vascular diseases

137

1.46

0.84

1.6

1.4

176.36

224.09

pmol/l

0.31

137

Benign neoplasm: Ascending colon

274

1.32

0.83

1.2

1.4

196.32

199.03

pmol/l

0.02

274

Other metabolic disorders

222

1.35

0.83

1.3

1.4

131.64

216.11

pmol/l

1.13

222

Symptoms and signs involving the digestive system and abdomen

545

2548

1.07

0.83

1.4

1.3

172.57

192.06

pmol/l

0.98

545

2548

Other and unspecified nerve root and plexus disorders, also in other diseases

734

1.19

0.83

1.4

1.3

153.72

181.20

pmol/l

0.89

734

Psoriasis (vulgaris), strict definition

140

0.57

0.83

1.3

1.4

228.88

235.83

pmol/l

—

140

Intracranial injury

216

2268

0.90

0.83

1.5

1.3

168.42

191.35

pmol/l

0.90

216

2268

Use of rivastigmine

111

0.54

0.83

1.2

1.3

114.82

142.48

pmol/l

—

111

Endometriosis

1.66

0.82

1.1

8.66

12.49

pmol/l

0.78

Benign neoplasm: Skin of lower limb, including hip

1.74

0.82

1.1

1.5

200.71

176.08

pmol/l

—

Non-allergic asthma (mode), excluding more controls

496

0.78

0.82

1.3

176.74

200.02

pmol/l

0.48

496

Scissor bite

1.66

0.82

1.2

1.3

153.44

195.12

pmol/l

0.46

Psychotic depression

146

1.44

0.82

1.5

162.14

179.21

pmol/l

0.24

146

Foreign body entering into or through eye or natural orifice

376

0.74

0.82

1.3

1.4

170.61

200.94

pmol/l

0.47

376

Tularaemia

1.89

0.82

1.0

1.3

242.17

171.84

pmol/l

—

Whooping cough

1.88

0.82

1.0

1.3

258.00

181.05

pmol/l

—

Acute otitis externa, noninfective

1.88

0.82

1.0

1.2

81.17

156.14

pmol/l

—

Pneumocystosis

1.88

0.82

1.7

1.6

121.42

157.43

pmol/l

—

Erythema nodosum

1.88

0.82

1.0

1.3

76.28

164.73

pmol/l

—

Asthma, unspecified (mode)

172

1457

0.89

0.82

1.3

159.05

185.57

pmol/l

1.75

172

1457

Other and unspecified corneal deformities and disorders

1.65

0.81

1.5

126.69

170.82

pmol/l

0.63

Crohn disease (strict definition, require KELA, min 2 HDR)

237

0.67

0.81

1.4

148.12

178.52

pmol/l

0.75

237

Exposure to other specified electric current

1.55

0.81

1.4

190.27

181.92

pmol/l

0.11

Gonococcal infection

1.55

0.81

1.4

199.08

170.52

pmol/l

0.43

Asthma, unspecified (mode), excluding more controls

172

1447

0.89

0.81

1.3

159.05

185.31

pmol/l

1.72

172

1447

Gonococcal infection

1.58

0.81

1.4

184.23

166.87

pmol/l

0.25

Other congenital malformations

201

0.65

0.81

1.3

1.4

139.04

215.39

pmol/l

0.74

201

Gastroduodenal ulcer

631

0.81

1.4

1.3

146.01

178.00

pmol/l

0.85

631

Hypoglycaemia, other or unspecified

201

0.65

0.81

1.3

1.4

307.04

213.76

pmol/l

0.27

201

Viral hepatitis, IBD co-morbidity

318

0.72

0.81

1.2

1.3

182.83

209.98

pmol/l

0.39

318

Other/unspecified synovitis and tenosynovitis

293

1.30

0.81

1.3

149.78

168.17

pmol/l

0.51

293

Colon adenocarcinoma

213

0.66

0.81

1.3

1.4

172.69

205.47

pmol/l

0.29

213

Pregnancy examination and test

0.51

0.81

1.0

1.1

7.86

44.68

pmol/l

—

Foreign body in ear

1.71

0.81

1.1

1.3

113.67

180.00

pmol/l

—

Other intracranial haemorrhages

1.71

0.80

1.3

1.2

165.34

182.30

pmol/l

—

Other systemic involvement of connective tissue

364

1.26

0.80

1.3

1.4

128.28

178.11

pmol/l

1.04

364

Sarcoidosis

418

1.25

0.80

1.3

1.4

150.63

187.75

pmol/l

0.78

418

Injuries to the elbow and forearm

238

2307

0.91

0.80

1.3

178.71

191.42

pmol/l

0.38

238

2307

Other and unspecified visual disturbances

215

1.35

0.80

1.3

1.4

145.03

205.78

pmol/l

0.64

215

Diabetic retinopathy, strict definition

331

0.75

0.80

1.3

1.5

115.75

155.30

pmol/l

0.64

331

Psoriasis vulgaris

697

0.82

0.80

1.3

1.4

141.78

185.36

pmol/l

1.42

697

Dorsalgia

476

2373

1.07

0.80

1.4

1.3

191.70

189.61

pmol/l

0.03

476

2373

Injury of cranial nerves

0.00

0.79

0.0

1.2

—

190.06

—

Disorders of male genital organs in diseases classified elsewhere

1.84

0.79

1.0

1.2

179.37

193.03

pmol/l

—

Other contact dermatitis

188

0.64

0.79

1.3

1.4

179.84

165.53

pmol/l

0.19

188

Carcinoid syndrome

0.00

0.79

0.0

1.2

—

162.70

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.79

0.0

1.2

—

172.87

—

Respiratory disorders in diseases classified elsewhere

0.00

0.79

0.0

1.3

—

162.28

—

Contusion of toe(s) with damage to nail

1.83

0.79

1.2

86.53

177.36

pmol/l

—

Horner syndrome

1.83

0.79

1.3

1.5

160.32

165.36

pmol/l

—

Other disorders of optic disc

1.83

0.79

1.0

1.5

199.88

170.86

pmol/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

139

1.44

0.79

1.6

1.4

140.67

160.69

pmol/l

0.46

139

Malignant melanoma of skin, including Hilmo

351

0.74

0.79

1.2

1.4

189.78

192.96

pmol/l

0.04

351

Focal epilepsy, strict definition

619

0.81

0.79

1.2

1.3

202.95

186.49

pmol/l

0.16

619

Misadventures to patients during surgical and medical care

312

1.28

0.79

1.4

128.85

195.23

pmol/l

1.27

312

Rheumatoid arthritis

615

0.82

0.79

1.3

138.58

170.94

pmol/l

1.81

615

Ulcerative proctitis

190

1.37

0.79

1.4

1.3

158.49

216.75

pmol/l

0.55

190

Corneal scars and opacities

1.67

0.79

1.6

1.4

187.88

171.26

pmol/l

—

Impetigo

150

0.60

0.78

1.0

1.3

158.48

170.71

pmol/l

—

150

Contusion of other and unspecified parts of foot

150

0.60

0.78

1.4

104.72

232.20

pmol/l

—

150

Glaucoma

110

1092

0.87

0.78

1.3

1.4

173.76

170.32

pmol/l

0.10

110

1092

Drug-induced osteoporosis

0.00

0.78

0.0

1.3

—

174.67

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.78

0.0

1.2

—

167.56

—

Necrosis of pulp, including avohilmo

234

2570

0.91

0.78

1.4

1.3

150.53

188.15

pmol/l

2.38

234

2570

Concussion

233

1722

1.10

0.78

1.4

1.3

165.32

188.74

pmol/l

2.19

233

1722

Malignant neoplasm of oral cavity

0.52

0.78

1.6

140.52

171.34

pmol/l

—

Presence of other devices

409

1.24

0.78

1.5

1.4

130.48

163.05

pmol/l

1.29

409

Epileptic seizures related to alcohol

0.00

0.78

0.0

1.3

—

161.16

—

Reiter disease

0.00

0.78

0.0

1.3

—

161.41

—

Malignant cancer of tonsil and base of tongue, including Hilmo

0.50

0.78

1.0

1.5

168.12

176.95

pmol/l

—

Covid-19 confirmed case

1074

0.86

0.78

1.5

1.3

150.78

175.51

pmol/l

0.99

1074

Dissocial personality disorder

100

0.50

0.78

1.2

1.5

153.10

178.32

pmol/l

—

100

Hyperkalaemia

123

0.57

0.78

1.6

1.5

81.81

181.09

pmol/l

—

123

Crohn disease

507

0.79

0.77

1.3

1.4

161.28

191.93

pmol/l

0.67

507

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.77

0.0

1.2

—

171.65

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Testosterone Free [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS